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With the rapid development of DNA synthesis technologies, synthetic biology has made tremendous 
progress in the past 15 years, in particular for synthetic genomics. Synthetic genomics is a nascent 
field of synthetic biology, which aims to design new biological systems/organisms to satisfy human 
needs. Conventional synthetic biology focuses on the redesign, construction and modeling of 
biological parts, pathways or genomes that do not exist in nature, while synthetic genomics 
encompasses technologies that allow the generation of chemically synthesized larger parts of 
genomes or whole genomes, with simultaneous redesign of an organism’s genetic material. Synthetic 
genomics is painting a blueprint for a new era of biology and holds great potential for a multitude of 
applications, such as pharmaceuticals, biofuels and rapid generation of vaccines against emerging 
diseases. 
Chapter One gives an introduction of the current state of the art and challenges of synthetic genomics 
and the objectives of this study. Chapter Two demonstrates the design and construction strategy of 
two megabase-long synthetic yeast chromosomes, SynII and SynVII. Chapter Three describes the full 
characterization of SynII and SynVII. Chapter Four introduces the SCRaMbLE (Synthetic 
Chromosome Rearrangement and Modification by LoxPsym-mediated Evolution) system and its 
application in SynII and SynVII. Taken together, this work demonstrates the utility of synthetic yeast 




“What I cannot create I do not understand” – Richard Feynman 
 
Over the past centuries a great deal of effort has been dedicated to understand the innerworkings of 
life, leading to our current understanding on biological processes underpinning many life forms on 
earth. Despite these advances, it remains unresolved whether we can rebuild or create biological 
systems in a laboratory setting, the only way to demonstrate we fully grasp the gist of how life works. 
The question remains largely unanswered until two decades ago when synthetic biology was 
developed: by combining principles from biology, computation, engineering and physics, researchers 
were able to create biological systems from scratch. And the complexity of built systems went from 
prokaryotes to eukaryotes, from a few genes to a whole genome. As a nascent field of synthetic 
biology, synthetic genomics uses aspects of artificial gene synthesis to create entire lifeforms, with 
simultaneous redesign of an organism’s genetic material. 
In the past 15 years, thanks to the rapid development of DNA synthesis technologies, synthetic 
genomics has made tremendous progress, showing great potentials in various applications, such as 
pharmaceuticals, biofuels and rapid generation of vaccines against emerging diseases.  
In this study, 1) new methods were developed to facilitate high efficient construction and 
characterization of synthetic chromosomes in yeast. 2) Two megabase-long yeast chromosomes, 
SynII and SynVII, were designed, constructed and fully characterized. And 3) an inducible genome 
rearrangement system was implemented in the synthetic yeast, which facilitates our understanding 
of fundamental biological systems and holds potential for industrial applications.  
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1.1 Yeast synthetic biology 
1.1.1 The state-of-art in synthetic biology and synthetic genomics 
One widely accepted definition refers to synthetic biology as the redesign of naturally existing 
biological systems, and de novo design and construction of new biological systems. The history of 
synthetic biology dates back to 1928 when Wöhler completed the synthesis of urea1. Since then and 
with the successful unraveling of the genetic code, synthetic biology was mainly focused on 
oligonucleotides or gene synthesis. One of the monumental accomplishments is the in vitro synthesis 
of a 207bp tyrosine suppressor tRNA gene by Khorana and coworkers in 19792. 
Development of tools for efficient genetic refactoring of biological parts, pathways and host chassis 
is imperative for successful re-engineering of existing biological systems. For instance, libraries of 
well-characterized promoter and terminator elements are helping synthetic biologists to optimize 
fluxes of the heterologously expressed pathways3, while genome-scale models help to properly 
incorporate synthetic gene networks within the intrinsic cellular metabolic pathways4. The 
development of DNA assembly technologies facilitates synthetic DNA construction. Methods such 
as enzymatic Gibson assembly5, Golden Gate assembly6 and MoClo assembly7 and the homologous 
recombination-based YOGE8 and VEGAS9 protocols allow for in vivo construction of genetic 
circuits and pathways. TAR cloning enables rapid capture of genetic circuits and pathways directly 
from more complex genomes through recombination machinery10, thus circumventing the need to de 
novo synthesize and amplify large DNA pieces. Finally, targeted DNA editing tools, such as the 
CRISPR-Cas system, make it possible to introduce multiplex modifications to the host genome11. 
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The remarkably fast-developing DNA synthesis, assembly and manipulation techniques have 
expanded synthetic biology studies from the simplest prokaryotic model systems to more complex 
eukaryotic model systems and helped bring forth synthetic genomics, a nascent field of synthetic 
biology. Synthetic genomics aims to design new biological systems/organisms to satisfy human 
needs. Conventional synthetic biology focuses on the redesign, construction and modeling of 
biological parts, pathways or genomes typically at a smaller scale, while synthetic genomics 
encompasses technologies that allow the generation of chemically synthesized larger parts of 
genomes or whole genomes, with simultaneous redesign of an organism’s genetic materials. Over 
the past decades progressive advancements have been made in synthetic genomics, which include 
the 7.5kb synthetic poliovirus in 200212, the 5.4kb synthetic φX174 phage in 200313, the 40kb 
refactored T7 phage in 200514 and the 1.1M “synthia” Mycoplasma genitalium genome in 201015. 
More recently synthetic genomics has taken another giant step forward and celebrated the success of 
de novo design and assembly of first eukaryote chromosomes from yeast16-22. Building upon these 
success, synthetic biologists even start to conceptualize writing more complex multicellular 
chromosomes and even the human genome23. 
The combination of computational design and de novo DNA synthesis enables the construction of 
re-designed genetic material, which is inaccessible to conventional biotechnological approaches. 
Synthetic genomics is painting a blueprint for a new era of biology and holds great potential for a 
multitude of applications, such as pharmaceuticals, biofuels and rapid generation of vaccines against 
emerging diseases. 
 
1.1.2 The state-of-art in yeast synthetic biology 
Among all the model organisms that are amenable to de novo synthesis from scratch, yeast stands 
out as one of the most powerful eukaryotic model organisms for several reasons. First, yeast is a 
simple unicellular organism whose molecular biology and genetics can often be readily related to 
higher eukaryotes, including humans. Second, most of the model yeast species possess the “Generally 
Regarded As Safe” (GRAS) status, and exhibit robust growth on inexpensive carbon sources. In 
addition, an increasing number of genetic engineering tools are readily available for these single-
celled fungi. Finally, yeast genomes are much more compact than their mammalian counterparts and 
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thus yeast cells are more convenient for studying complex cellular processes, excepting 
developmental studies. 
 
Among different species of yeasts, baker’s yeast S. cerevisiae is undoubtedly the most well-
established eukaryotic model organism, whose remarkable ability for efficient homologous 
recombination has made it one of the main synthetic biology chassis. But S. cerevisiae is not the only 
model yeast to answer the fundamental cell biology questions. Fission yeast Schizosaccharomyces 
pombe (S. pombe), for example, has been extensively studied to investigate cell cycle control 
mechanisms24,25. In the following parts, a few examples from different angles are shown to elaborate 
on the current status of applying synthetic biology approach to yeast models.  
 
Synthetic yeasts reveal natural cellular functions 
In the past few years synthetic biology has greatly enhanced our understanding of natural biological 
processes mainly by constructing in-vitro/in-vivo pathways and networks to interrogate specific 
biological functions26,27. Direct testing custom-built networks or systems in living cells enables the 
researches to obtain readouts of synthetic biological elements in the cellular contexts, by which also 
enriches our understanding of natural systems. To date, synthetic biology studies in bacterial system 
have made tremendous advances largely due to its well-defined cellular components and simplicity28. 
More recently synthetic biologists have also successfully demonstrated the feasibility and utility of 
constructing synthetic regulatory networks to recapitulate various cellular functions in the more 
complex eukaryotic system, the yeast.  
 
Synthetic gene expression programs 
Modulation of gene expression levels is essential in metabolic engineering for optimized production29. 
Eukaryotic cells possess a sophisticated program evolved naturally for precise control over gene 
activation/suppression in various cellular processes and/or in response to external stimuli. Design 
and implementation of novel gene regulatory programs will not only provide a new level of 
understanding for many natural biological processes but also facilitate engineered designer cells for 
biotechnological applications. In general, gene expression can be regulated at the levels of 
transcription, post-transcriptional modification (such as RNA splicing and histone mRNA processing) 
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and translation. The following brief survey on gene expression regulation is accompanied by a 
discussion of synthetic approaches via transcriptional and translational engineering (Figure 1.1). 
The cis regulatory elements including promoters, 5’ or 3’ UTRs and introns are involved in the 
regulation of gene expression. Many studies have generated synthetic promoter libraries to fine-tune 
gene expression. In eukaryotic cells, RNA splicing also plays a key role in controlling the levels of 
gene expression. Yofe et al. constructed a S. cerevisiae intron reporter library and developed a model 
based on this library to study the rules of intron-mediated regulation of gene expression30. In their 
study, hundreds of native yeast introns were individually cloned in front of a yellow fluorescent 
protein (YFP) cassette to access their effects on the regulation of YFP expression. In agreement with 
previous studies, the authors found that intron-exon junction structure (RNA secondary structure), 
transcript GC content and splicing regulatory elements have impacts on gene expression levels31,32. 
Intriguingly, they observed no correlation between intron length and gene expression levels.  
 
Apart from engineering transcription regulatory elements, locus-specific regulation can also be 
achieved by repurposing CRISPR single-guide RNA (sgRNA) as scaffolding molecules with protein 
recruitment capabilities33. Zalatan et al. designed a scaffold RNA (scRNA) by individually 
connecting RNA hairpin domain to the CRISPR sgRNA at the 3’ end with a linker sequence. Three 
well-characterized viral RNA sequences MS2, PP7 and com were selected as recruitment RNA 
modules, while their corresponding RNA binding proteins MCP, PCP and Com were also 
individually engineered by fusing with transcriptional activation domain VP64. The transcriptional 
activation capability of this system was tested in a dCas9 expressing yeast strain with a fluorescent 
protein reporter driven by a tet-promoter. The results showed the scRNA-protein recruitment 
modules could strongly activate reporter gene expression in an orthogonal manner. In addition, they 
also found that by manipulating the numbers of recruitment motif and combining a mixture of 
recruitment RNA modules, their CRISPR scRNA platform can achieve site-specific tunable 
multiplexing gene activation.  
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Riboswitches are RNA-only molecules, which constitute an attractive tool for translational 
regulation34. There are two functional domains in a riboswitch - an ligand-binding aptamer domain 
and an expression platform that determines system output35. By engineering aptamer ligand complex, 
programmable transcriptional and translational regulation can be achieved36,37. Grate et al. 
engineered a synthetic cyclin transcript CLB2 in budding yeast by inserting a malachite green binding 
aptamer into CLB2 5’-UTR to regulate expression of CLB2 protein, and thereby controlling the yeast 
cell cycle38. RT-PCR and Western blot analysis revealed that aptamer insertion limited the binding 
of 40S ribosomal submit to the CLB2 5’-UTR, which led to a reduced rate of translational initiation. 
These results indicate that aptamer-mediated mRNA translation efficiency was affected rather than 
mRNA stability36. In another study, Hanson et al. further investigated the correlation between 
translation efficiency and insertion positions within the 5’-UTR using a tetracycline-aptamer-
mediated translational regulation system37. In their study, the tetracycline-binding aptamer was 
inserted into the 5’-UTR of a luciferase gene LUC either at a cap-proximal position (9bp from the 
cap site) or a cap-distal position (5bp preceding the start codon). The results showed that tetracycline 
binding to its cognate aptamer located in LUC mRNA could trigger strong inhibition of translation, 
while aptamer insertion in cap-distal position was more effective than the cap-proximal position. In 
sum, these studies all successfully demonstrate the robustness and versatility of synthetic 




Figure 1.1 Gene expression regulation through synthetic functional parts 
Gene expression can be regulated through following approaches: Synthetic promoters, UTRs have been 
engineered to regulate gene expression level during transcription process, while synthetic introns have 
been used for the same purpose during post-transcription process. CRISPR/dCas9 system has also 
been engineered and used as synthetic transcriptional factors for gene expression regulation both 
positively and negatively. Riboswitch has been developed to stop translation by folding and closing 
ribosome binding site (RBS) after its aptamer binding different ligands. Codon optimization has also been 
wildly used for gene expression regulation. Green arrow indicates promotion, while red blocked line 
indicates repression. 
 
Synthetic systems for emulating fundamental biological processes 
Design and testing of synthetic systems in living cells represents a unique approach to reveal key 
biological principles to fill the gaps of our understanding of natural systems. Prokaryotic synthetic 
circuits have been well established for studying biological processes with rationally predefined 
parts26. More recently, synthetic systems that function properly in eukaryotic cells have also been 
developed for emulating some of the fundamental biological processes, such as cell differentiation. 
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Cell differentiation involves the generation of binary responses from positive feedbacks of 
transcriptional regulators. Two factors pose the challenge of understanding the regulatory 
mechanisms underlying positive feedbacks of eukaryotic transcription: unidentified transcription 
factors and poorly understood the model of “enhancer” action. To address this issue, Becskei et al. 
deployed a synthetic eukaryotic gene switch in S. cerevisiae using well-defined constitutive 
promoters and tetracycline-responsive trans-activator (rtTA) to activate the expression of a 
chromosomal integrated reporter construct39 (Figure 1.2). They took advantage of rtTA, which is 
capable of generating a graded response in constitutive system by either changing the gene copy 
number or adjusting the concentration of inducer doxycycline, to investigate positive feedback with 
a mathematical model they built. Two distinct subpopulations of cells, “on” and “off” cells, could be 
identified in this simplified gene activation system. With increased inducer concentrations the 
number of “on” cells marked by fluorescence goes up, while the number of “off” cells that don’t have 
fluorescent signal goes down. As another example, Ajo-Franklin et al. successfully applied a 
rationally designed synthetic positive feedback network to achieve sustained transcriptional 
activation upon a transient stimulus40. The synthetic device consists two modules that are both under 
the control of an inducible promoter: synthetic factors labeled by fluorescent protein (activator) and 
their cognate transcriptional targets (reporter) (Figure 1.2). They evaluated the functionality of the 
introduced activator and reporter upon transcriptional induction and over several cell generations 
following sustained gene activation, and also quantified their effects on gene expression. The results 
showed that a simple well-defined synthetic circuit with positive feedback loop could generate long-
term cellular memory, which holds potential for mechanistic understanding of positive feedback 








Figure 1.2 Synthetic network for emulating cell differentiation process 
A positive feedback genetic circuit, which could generate binary responses from positive feedbacks of 
transcriptional activator, is designed and incorporated into engineered yeast. This system is capable of 
generating a graded response: with increased inducer concentrations the number of “on” cells marked 




Engineered yeasts with novel functions 
The above-mentioned pioneering studies applying simple synthetic systems to yeast aim to describe 
and understand intrinsic cellular properties and functions. In addition, there are also efforts 
attempting to rewire cellular physiology by implementing completely novel functions, such as 
artificial cell-to-cell communication, which offer the possibility to control cellular behavior at the 
population level. Cell-cell communication is a widely adopted natural process in both prokaryotes 
and eukaryotes: in prokaryotes cell-cell communication is mostly based on quorum sensing of small 
diffusible molecules41, while in eukaryotes like yeast is mostly mediated by pheromones42. In recent 
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studies, both approaches have been successfully re-engineered and implemented within host yeast 
cells to achieve artificial cellular communication for various purposes43: 
 
Engineered yeasts with quorum sensing function 
Bacterial cell-cell communication driven by quorum sensing depends on the utilization of small 
diffusible molecules (also referred as autoinducers), such as N-acylhomoserine lactones (AHLs), 2-
alkyl-4-quinolones (AQs) and 2-heptyl-4(1H)-quinolones (HHQ)41. Sender cells signed receiver cells 
generating a density-dependent response within the entire population. A similar approach has also 
been applied to yeast cells by incorporating signaling pathway components from other species for 
quorum sensing behaviors in yeast. Chen and Weiss used the plant hormone isopentenyladenine (IP) 
originated from Arabidopsis thaliana as an intercellular signaling molecule and its corresponding 
receptors to achieve positive feedback quorum sensing function in S. cerevisiae yeast44 (Figure 1.2a). 
In this system, “sender” cells are engineered to synthesize diffusible cytokinin IP, which can activate 
the expression of IP receptor AcCRE1 and subsequently activate its downstream nuclear aspartate 
response regulator SKN7 in neighboring engineered “receiver” cells, which can further activate the 
synthetic SKN7 response promoter driven GFP reporter in a density-dependent manner (that is, 
quorum sensing). As another example, Khakhar et al. utilized plant hormone auxin and CRISPR 
transcription factors to engineer “sender” cells and “receiver” cells for orthogonal and tunable cell-
cell communication45. A large part of the indole-3-acetamide (IAM) pathway from Agrobacterium 
tumefaciens was integrated into “sender” yeast cells so that the cells can produce auxin by converting 
IAM provided in the culture medium, while “receiver” cells were engineered to co-express a fusion 
protein, which contains dCas9, an auxin-sensitive degron from Arabidopsis46, a transcriptional 
activator, and a CRISPR guide RNA specific to a GFP reporter. When exposed to IAM, “receiver” 
cells express GFP in the absence of “sender” cells, and during co-culturing of both cells, auxin 
produced by “sender” cells can trigger the degradation of the fusion protein and subsequently lead to 
a reduction of GFP expression in “receiver” cells. Both examples mentioned above share several 
important features such as orthogonality to host cellular machinery, tunability and easy-to-
reconfigure. These features make synthetic quorum sensing system a unique approach to investigate 




Figure 1.3 Engineered yeasts with quorum sensing function 
Engineered “Sender” module enables the yeast to produce autoinducers, while engineered “Receiver” 
module enables the cells to sense the autoinducers and activate the downstream pathways encoded by 
the control module (positive feedback loop and GFP reporter as example here). These three modules 
incorporated in yeast cells can lead to density-dependent population behaviors. Each module was 
simplified and represented by one transcriptional unit. 
 
Engineered yeasts with biological computation function 
Computation by engineered biological system has also become an emerging research subject in 
synthetic biology47. AND gates48, multi-input logic gates49, counting50 and oscillators51 have been 
achieved in re-engineered prokaryotic cells. Similarly, synthetic biologists also successfully re-
engineered eukaryotic cells in single population, as well as multiple subpopulations, to perform logic 
operations.  
 
Win and Smolke engineered RNA-based devices and developed a framework for using these RNA 
devices to perform cellular information processing, transduction and control operations in a single 
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yeast population52 (Figure 1.4). The single-input/output RNA devices are assembled with three 
modules: a sensing module (an RNA aptamer), an actuation module (a hammerhead ribozyme) and 
a transmitter module designed to couple both sensing and actuation modules. The RNA device is 
imbedded in the 3’UTR region of the target gene. By adding input molecules, the input-sensor 
binding will lead to the activation of actuation module, i.e. self-cleavage of ribozyme and 
subsequently inactivate the target gene expression. The authors also succeeded in extending the 
utility of the engineered RNA device by using different module assembly strategies and different 
integration sites so that the assembled devices can perform logic operations (AND, NOR, OR and 
NAND gates) and signal filtering in a cooperative manner. When it comes to highly complex 
computational tasks, engineering in single cell population is challenging as it would require 
functional integration of many more complex regulatory components, which often introduces 
metabolic burdens to the cells. To overcome this one possible solution is to implement different 
computation modules separately into each subpopulation of the microbial consortium (also called as 
distributed computation) to simplify the design and optimization of logic functions and reduce 
potential metabolic burdens. In general, distributed computation can be achieved by combining logic 
function devices and efficient cell-cell communication system. As a proof-of-principle, Regot et al. 
managed to perform a broad variety of computational functions with only a small library of 
engineered yeast cells with each subpopulation only responds to one external input and/or one single 
diffusible molecule for wiring purpose53. Another advantage of this strategy is that instead of 
engineering a highly complicated single-cell type derived system, each engineered cell type is 
reusable and can act as functional modules to complete more complicated computing task. 
 
To summarize, the design and implementation of biological computing systems in either single or 
multiple cell populations can greatly enhance our ability to learn and further control existing 




Figure 1.4 Engineered yeasts with biological computation function 
Novel biological computation function created by RNA devices (upper panel) and distributed computation 
(middle panel) were illustrated. The RNA devices used to create biological computation function is 
composed with different sensor molecules, transmitter molecules and actuator molecules. When input 
signal molecules are sensed by the sensors, the signal will transmit to actuator by the transmitter, and 
the devices located at the 3’UTR will transform into either “ribozyme-active” state that results in self-
cleavage (indicate by scissor icon) of transcript or “ribosome-inactive” state that stop self-cleavage. The 
distributed computation consists of different subpopulation cell (lower panel). Different subpopulations 
were engineered differently so that they played different roles in the computation. 
 
Engineered yeasts with versatile social behaviors 
Natural ecosystems are highly complex and not well understood due to challenges in multi-
parameters analysis and lack of manipulation tools. Synthetic ecosystems designed to recapitulate 
key features of natural ecological habitats, on the other hand, hold the promise to dissect major factors 
underlying specific ecosystem behaviors and therefore has led to a growing interest in studying 
prokaryotic and eukaryotic consortium54,55.  
One important feature often observed in natural ecosystems is symbiosis, the co-existence of 
organisms from the same or different species in a cooperative manner such that each species benefits 
from the other’s activity. Symbiosis has also been studied in a synthetic biology context. Shou et al. 
studied cooperative interactions between two engineered yeast populations that have no prior known 
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interaction by constructing a synthetic obligatory cooperative system56 (Figure 1.5). Two auxotrophic 
yeast strains with same mating type were selected: one requires adenine and the other requires lysine. 
Co-culturing of these two strains in the absence of adenine and lysine will lead to eventually death 
of both strains. To create a cooperative behavior, each strain was genetically modified with one 
requiring adenine but overproducing lysine, while the other required lysine but overproduced adenine. 
By co-culturing the two mutant yeast strains together, nutritional cross feeding is established. This is 
reflective of the obligate mutualistic system that both populations need to constantly cooperate to 
survive, which provide insights of population dynamics of co-habituating communities. 
 
The above example focuses on how cooperative entities sacrifice to survive in an ecosystem at a cost 
to themselves. In nature, there is another cooperative interaction with nonlinear benefits been 
incorporated when exploiters or cheaters reap the benefits from the cooperators and forego costs. 
Investigating this cooperative behavior in a multi-agent competing system, also known as snowdrift 
game, will provide insights into the origin of coexistence of cooperators and cheaters during 
evolution. Gore et al. investigated the snowdrift game dynamics with a synthetic ecosystem in which 
histidine auxotrophic strains serve as the cooperator, which secretes invertase to hydrolyse sucrose 
outside the cytoplasm, and a mutant strain lacking an invertase gene as the cheater57 (Figure 1.5). 
The cooperator cells can utilize sucrose, the only carbon source provided in the culture, to grow, 
while the cheater cells cannot grow on their own but instead benefit from the sugars produced by 
cooperator cells. By adjusting the amount of histidine supplement as well as the glucose 
concentration, the authors were able to alter the competition outcomes, which shed light on the 
mechanisms underpinning cooperation in nature. 
 
In a recent study, the sociability of yeast cells, i.e. self-communication (asocial behavior) and 
neighbor-communication (social behavior), was also successfully manipulated by engineering yeast 
cells to secrete and sense the mating pheromone58 (Figure 1.5). Youk and Lim imbedded a synthetic 
secrete-and-sense circuit in the budding yeast cells, which enabled the cells to secrete and sense α-
factor. As a response after sensing the mating pheromone, the engineered cell would express GFP 
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under the control of the α-factor-responsive FUS1 promoter. By co-culturing with “sense-only” cells 
that can only sense α-factor but cannot produce α-factor, self-communication and neighbor-
communication could be distinguished. The authors also studied the key parameters affecting the 
social mode such as cell density and α-factor secretion rate. Finally by engineering a positive 
feedback strain expressing Bar1 protease, that degrades α-factor, they achieved tunable ratios of 
biomodal population. This impressive approach successfully measured the effects of synthetic circuit 
on intra/inter-cellular interactions and population-level behaviors, which could further help 
understand higher-order multicellular behaviors. 
 
It is exciting to see that synthetic ecosystems have been widely adopted to help us understand the key 
factors affecting the microbial communities and study ecological theories. Benefiting from their 
reduced complexity and improved manageability when compared to natural ecosystems, synthetic 
ecosystems found their way into not only fundamental research, but also practical applications such 
as industrial production of chemicals and bioremediation of contaminated areas59.  
 
  
Figure 1.5 Engineered yeasts with versatile social behaviors 
“Symbiosis” behavior has been achieved by engineering two yeast populations carrying two different 
auxotrophic marker to establish nutritional cross feeding.  “cooperator-cheater” dynamics has been 
accomplished by modulating the amount of nutrition supplement and carbon source of culture, in which 
two different engineered yeast populations were cultured. One population can utilize the carbon source 
directly to produce sugar, while the other can only survive with the produced sugar. Asocial/Social 
behavior has been manipulated by engineering yeast cells to secrete and sense the mating pheromone.  
 30 
 
Apart from being used as tools for answering fundamental biological questions, yeast has also served 
as the industrial production workhorse for centuries. In addition to its traditional use in alcoholic 
beverages manufacturing, yeast has now become specialized cellular “factories” whose genomes and 
native metabolism pathways are amenable to extensive re-engineering. One prominent example is 
the production of artemisinic acid in baker’s yeast60. By modifying the native yeast mevalonate 
pathway and expression of the A. annua amorphadiene synthase and cytochrome P450 
monooxygenase genes, researchers successfully re-directed the yeast metabolic flux towards a high-
yield production of the drug precursor, achieving titers of up to 100 mg per liter. The artemisinic acid 
could be secreted from the engineered yeast cells, which allowed for an easy and low-cost purification 
of the product, opening a possibility for scale-up industrial productions. 
 
To summarize, in this section, several successful examples of synthetic biology-driven approaches 
using yeast have been described. These covered a wide range of diverse scientific initiatives, which 
include: building custom genetic circuits to unravel native cellular mechanisms, introducing novel 
functions to yeast chassis as well as re-wiring the host metabolism to produce value-added chemicals 
and proteins. The capability of using synthetic biology tools in yeast is based on quantitatively 
predicting the synthetic system’s behavior and implementing cellular modifications. By applying 
tools including DNA assembly techniques, recombinant DNA techniques, pathway modification and 
analysis, genome-scale engineering and modeling, synthetic yeast has been widely used for 
improving our understanding of fundamental biology as well as developing a multitude of practical 
applications. 
 
1.2 Current challenges of synthetic genomics 
As reviewed in the previous section, synthetic biology has shown great potential in integrating 
engineered parts or modules into existing biological systems for novel functions. As for the ultimate 
goal of synthetic genomics, however, currently there are, among others, four grand challenges need 
to be addressed: 
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First, following the idea of “build to understand”, we have seen how synthetic biology can transform 
our basic understanding of life forms. However, we also need to admit that it is still far fetched de 
novo design and create artificial life forms. And therefore most, if not all, synthetic biology studies 
are largely designed to facilitate our understanding of existing life form. Taking the first synthetic 
life form Synthia (Syn1.0) as an example, the 1079–kilobase pair (kbp) synthetic genome of M. 
mycoides contains 901 genes61. Recently Synthia genome was further reduced to a 531kbp containing 
473 genes through several cycles of design, synthesis, and testing 62. And surprisingly, there are still 
149 genes, 30% of the whole genome, have unknown biological functions that are essential for life. 
Creating a truly living and dividing cell from scratch by de novo synthesis requires the 
comprehensive knowledge of genes essential for life and how each gene functions and interacts. 
Despite the fact that model prokaryotic and eukaryotic organisms such as E. coli and budding yeast 
S.cerevisiae have been extensively studied over decades, our understanding is still limited. In 
addition, many widely used industrial strains were chosen based on historical rather than scientific 
grounds. Therefore, extensive genetic and phenotypic studies of nonconventional organisms are 
warranted to improve our knowledge and provide more guidance during synthetic genomic design.  
 
Second, the entire Mycoplasma genitalium (M. genitalium) genome was synthesized from 
oligonucleotides, assembled in budding yeast into a complete genome. This genome transplantation 
method heavily depends on accurate design of a viable genome, and the low success rate of the 
transplantation step makes it challenging to restore fitness when defects arise. The issue here can be 
even more problematic if the complexity and size of the target genome increases significantly. 
Therefore, highly-efficient construction strategies, that can be applied to various systems, are crucial. 
In addition, establishing high-efficient methods for detecting bugs and debugging is also crucial since 




Third, for a designer genome, maintaining a near wild type viability is one of the most essential 
requirements, which is important for further engineering, evolution and applications in subsequent 
studies. Apart from genotype confirmation by sequencing, phenotypic assays, such as monitoring 
growth and cell morphology, are normally applied to test the viability of the synthetic cells. However, 
this strategy is only applied when a fitness defect has been detected. Again, considering the increase 
in complexity of designer genome in the future, the lack of in depth characterization strategies could 
potentially lead to great amount of unnecessary troubleshooting efforts. Therefore, comprehensive 
and systematic characterization strategies are required which thoroughly interrogate of the function 
of designer cells. Such strategies will identify subtle changes not detected by phenotypic analysis and 
also reveal functions of certain synthetic elements.  
 
Last but not least, from Synthia to the world first synthetic eukaryotic chromosome then to the 
announcement of The Genome Project-Write23, we foresee an ever-increasing demand of DNA 
synthesis for synthetic genomics. Even though the cost of DNA synthesis has been steadily 
decreasing over the last few years, it is still exceedingly expensive and time consuming to construct 
an entire eukaryotic genome. Therefore, future efforts to overcome this limitation are necessary. In 
this regard, automated DNA synthesis and assembly technologies and platforms constitute a very 
promising direction to further reduce the cost as well as increase the throughput.  
 
Currently, as mentioned above, synthetic genomics is faced with various mounting challenges both 
technically and scientifically. With dedicated efforts, however, these difficulties will eventually be 
overcome and the full potential of synthetic genomics will be unlocked in the future, which 
consequently will bring about a paradigm shift in biotechnological research and applications. 
 
1.3 Introduction of Sc2.0 
Apart from application-driven genome scale manipulations with genome engineering tools such as 
CRISPR-Cas systems63-65, synthetic genomics can also be used to answer a wide variety of questions 
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about fundamental properties of genome structure and organization, gene content, and genome 
evolution. Re-engineering the whole genome has been achieved in virus and bacteria12,15. Re-
engineering eukaryotic genome poses more challenges due to the increased complexity. Regardless 
however, significant progresses have already been made recently with the eukaryotic organism yeast.  
 
Background of Sc2.0 project 
The Sc2.0 project, which aims to re-design and synthesize all 16 chromosomes to build an entire 
synthetic S. cerevisiae genome, is considered to be one of the most ambitious current synthetic 
genomics projects. Three principles are developed to guide the genome design, namely genome 
viability, stability and flexibility. Based on these principles, several design elements are incorporated 
to generate the synthetic genomes (Figure 1.6). First of all, a number of non-essential features, such 
as transposons, introns with annotation of non-essential functions, sub-telomeric repeats, are deleted 
from the blueprint genome. Furthermore, one of the three stop codons is eliminated from the genome 
to allow the incorporation of an alternative artificial amino acid, by which protein properties can be 
altered. tRNAs are known regions of genome instability66,67, therefore, in order to isolate the hotspots 
for transposition and genome rearrangements from synthetic chromosomes, all tRNAs are relocated 
to a separate “neochromosome” for overall increased genome stability. Together, these modifications 
lead to a roughly 4-21% reduction of chromosome size in Sc2.0 yeast (Table 1.1). The most novel 
element in Sc2.0 is the introduction of LoxPsym site that flanks each non-essential gene in all 
synthetic chromosomes. By doing so, it could, in theory, generate combinatorial genomic diversity 
through rearrangements at designed sites upon expression of Cre recombinase, which is designated 
as “SCRaMbLE” (Synthetic Chromosome Rearrangement and Modification by LoxP-mediated 
Evolution). The power of this build-in tool has been demonstrated by Shen et al. on Synthetic 




Figure 1.6 Sc2.0 Design principles and design summary 
Four types of designs are introduced: retrotransposons, subtelomeric repeats and introns with annotation 
of non-essential function (* ribosomal related introns are not deleted in designer sequence due to their 
role in maintaining cell viability69) are removed. All tRNA genes are relocated to a separate 
“neochromosome” for overall increased genome stability. TAG stop codons are replaced by TAA stop 
codon to allow the incorporation of an alternative artificial amino acid and universal telomere of the simple 
~350bp sequence repeat (TG1-3)n is incorporated to replace original telomeres. PCRTags are alterations 
incorporated into most open reading frames (ORFs) and served as water marker. LoxPsym site that 
flanks each non-essential gene in all synthetic chromosomes is used as a tool to induce designated 
genome rearrangement.  
 
All above mentioned design principles are incorporated into the design sequence in silico using the 
in-house developed software “Biostudio”70. Each designer chromosome sequence is then divided in 
a hierarchical order into megachunks (~30-50kb), chunks (~10-15kb), minichunks (~2-3kb), building 
blocks (~750bp) and oligos (~60-80bp) to facilitate a step-wise construction. To accelerate the 
completion of Sc2.0 project, 9 institutes from US, UK, China, Australia and Singapore were assigned 
the task of different chromosomes and proceed independently. The general construction strategy is 
called “SwAP-In” (Switching Auxotrophies Progressively for Integration), which takes the 
advantage of the high-efficient homologous recombination in yeast to facilitate the replacement of 
native sequence with corresponding synthetic sequence. In order to further accelerate the progress, 
different construction strategies are also developed in the Sc2.0 consortium. For example, SynII and 
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SynVII are constructed from two initial strains in parallel and combined by I-SceI mediated method18 
(detailed method can be found in Chapter Two), while SynXII was built from six initial strains and 
combined by meiotic recombination-mediated assembly strategy22. To generate the final synthetic 
yeast, carrying all synthetic designer chromosomes, a meiotic-mediated method called 




 Table 1.1. Summary statistics for design of Sc2.0  
(WT, wild type; SYN, synthetic.) 
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To date, 6.5 chromosomes have been constructed, with 2.5 chromosomes consolidated into one strain. 
Once finished the hope of Sc2.0 synthetic genome will serve as a powerful analytical tool to enhance 
our knowledge of yeast biology.  
 
1.4 Objectives of this study – SynII & SynVII 
Among the 16 chromosomes, SynII and SynVII are considered relatively long chromosomes. The 
native chromosome II is 807 kb in length and includes 410 open reading frames, 13 tRNAs, and 30 
introns(13), while the native chromosome VII is 1090 kb in length, carrying 583 coding genes, 36 
tRNAs and 26 introns71. SynII and SynVII were designed based on the native sequence following 
rules mentioned above, resulting in two “designer” chromosomes 770 kb and 1029 kb in length. Both 
are 5% shorter than their native counterparts. The current study focuses on using SynII and SynVII to 
explore the following topics: 
 
Construction strategy 
Current construction strategy “SwAP-In” works very well for small chromosomes, such as 
chromosome I or III, as it only requires a few runs to complete the construction. However, it does 
not work efficiently for megabase long chromosomes like II or VII. Any unexpected problem during 
the construction will stall the entire process. Therefore, a high-efficient construction strategy, 
especially for large chromosomes, is necessary and could be potentially applied to other large 
chromosome constructions in the future. 
 
Comprehensive phenotypic assays 
For each designer chromosome in Sc2.0 projects, thousands of changes have been introduced, which 
naturally raises the questions whether there are any phenotypic impacts and how to quickly identify 
the cause. Classical phenotypic assays would not be enough to reveal subtle changes. Therefore, more 
in-depth analysis should be established, e.g. examining DNA, RNA, protein and metabolic profiles, 
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checking 3D genome structure and monitoring cell replication and segregation. For defect mapping, 
the modular construction approach applied in Sc2.0 project provides an important mechanism to 
systematically discover and repair phenotypic defects during construction. Therefore, it will greatly 
reduce the workload of debugging by narrowing down the target into one 30-50 kb megachunk region. 
However, additional efforts are still needed for efficient detection and targeting defect regions. 
 
Use of SCRaMbLE to select novel properties 
One of the most novel elements in Sc2.0 is the SCRaMbLE system. By incorporating SCRaMbLE, 
the designer Sc2.0 yeast genome holds the potential to be further evolved, generating strains that 
encode various phenotypes. It will be interesting to see if SCRaMbLE allows designer yeast cells to 
quickly adapt to specific stress conditions and how the genome diversity introduced by SCRaMbLE 
can be used as a resource to study scientific questions. 
 
1.5 Thesis outline 
This thesis is structured as follows. Chapter Two presents the construction of SynII and SynVII. 
Section 2.2 introduces the use of acoustic dispensing technology to facilitate DNA assembly at very 
low volumes. The construction and variation repair of both synthetic chromosomes are described in 
Section 2.3 and 2.4. Chapter Three focuses on the full fitness characterization and fitness defect 
rescue of SynII and SynVII. Chapter Four is devoted to the introduction of SCRaMbLE system. The 
sequence reconstruction workflow using deep sequencing data is described in Section 4.1. Next, 
using SCRaMbLE to rescue the fitness defect in SynII is demonstrated in Section 4.2. Finally, 
Chapter Five points the conclusions and possible future research directions. 
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1.6 Summary of contributions 
The design of SynII and SynVII was accomplished by team led by Dr. Jef Boeke and Dr. Joel Bader. 
The majority of work for SynII and SynVIIR construction was done by Tai Chen and Yang Deng from 
BGI. Construction of SynVIIL, structure variation repairing of SynII and SynVII, and biological 
characterization were accomplished by myself. Work of DNA assembly methodology with acoustic 
dispensing technology was led by Paulina Kanigowska, myself and Sarah Zheng. Bioinformatics 
analysis workflow was co-developed by me, Yun Wang and Giovanni Stracquadanio. SCRaMbLE 





Part 1: Build - the design and construction of two megabase long yeast 
chromosomes 
 
2.1 Overview of Sc2.0 chromosome design and construction strategy 
The Sc2.0 chromosome design was specific to S. cerevisiae reference sequence based on the S288c 
wild type strain derivatives [reference version updated by the Saccharomyces Genome Database 
(SGD) on February 3rd 2011]. A series of edits including deletions, insertions and base substitutions 
were introduced to the reference sequence of each chromosome by BioStudio design suite70 followed 
by manual check. For each step, a version number was created. Take SynII as example, version 
2_0_00 refers to the wild type sequence, while 2_1_00 indicates an intermediate SynII sequence with 
PCRTags added. Then stop codon swap, loxpsym site insertion and intermediate editing steps were 
introduced, generating the final version 2_3_22. 
Complete chromosome re-design was performed using the BioStudio design suite70 conforming to 
the Sc2.0 project standards to yield the synthetic yeast chromosome II and VII (termed SynII and 
SynVII). Relative to the wild-type reference sequences, SynII has 33 deletions (53,605bp in total), 
269 insertions (10,456 bp in total) and 14,949 single nucleotide substitutions, while SynVII has 93 
deletions (69,292 bp in total), 380 insertions (12,920 bp in total) and 20,745 single nucleotide 
substitutions (Table 2.1, Table 2.2). Although SynII and SynVII reflect 5.3% and 5.7% reductions in 
size compared to the native chromosomes, hundreds of designer features were incorporated 




Table 2.1 Summary of SynII design 
a. Wild-type telomeres together with its adjacent subtelomeric regions are replaced with universal 
telomere caps. b. Unique restriction sites were generated in SynII either by introduction of synonymous 
mutations in ORFs, or by removal of redundant sites to leave only one pre-existing restriction site in the 
SynII sequence. c. Transposable element region include the functional features of LTR retrotransposons, 
transposable element genes and long terminal repeats. d. Eight introns were retained as they reside in 
ribosomal subunit coding genes. 
 
 
Table 2.2 Summary of SynVII design 
Description of a. to c. is the same with Table 2.1. d. Eleven introns were retained as they reside in 




Table 2.3 Comparison between wild-type and synthetic chromosomes II and VII 
“chr02_0_0” and “chr07_0_0” refer to wild-type chromosome II and VII respectively, and “chr02_3_22” 
and “chr07_3_57” refer to SynII and SynVII respectively. 
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Compared with previous strategies16,17, an alternative modular assembly method was devised for the 
construction of SynII and SynVII. This new approach enables parallel integration to speed assembly, 
while at the same time also provides an effective way to debug potential phenotypic defects (see 
below in section 2.3.2). SynII and SynVII were divided into 25 megachunks (~30 kb each) using 
BioStudio, and each megachunk was then segmented using in-house software “Segman” into 
minichunks (~3 kb, Figure 2.1), which are compatible with the Gibson assembly method5 (Figure 




Figure 2.1 Synthetic chromosome hierarchical nomenclature 
An entire synthetic chromosome (green) is segmented stepwise into ~30 kb megachunks (dark red), ~10 
kb chunks (dark blue) and ~3 kb minichunks (light blue) according to the experimental design.  
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Instead of performing step-by-step megachunk integration (SwAP-In)70 from one end (left or right 
arm), I performed integration in parallel from both ends with two separate parental strains YS000-L 
and YS000-R (Figure 2.2B) bearing SynII-L/SynVII-L and SynII-R/SynVII-R respectively, which 
overlap by 30 kb, effectively reducing the overall integration time by almost 50%. These two strains 
were crossed to produce a heterozygous diploid. Regions bearing substantial sequence similarity to 
the native chromosome remain and might trigger various unwanted meiotic recombination events, 
which would result in tremendous screening efforts when combining semi-synthetic chromosomes 
via homology-directly recombination. Therefore, to increase the frequency of mitotic recombination 
between two semi-synthetic chromosomes (SynII-L/SynVII-L and SynII-R/SynVII-R), an I-SceI 
mediated strategy72 was adopted to break both semi-synthetic chromosomes at a designed site, 
promoting mitotic recombination between them to generate the fully synthetic chromosome (Figure 
2.2C). Induction of the lethal I-SceI-mediated DNA double-strand breaks at the junctions of synthetic 
and wild-type sequence introduced a strong selective pressure for the two semi-synthetic segments 
to recombine, via a HDR mechanism. Since our recombination strategy is designed to generate a 
marker-less synthetic chromosome and leave the URA3 marker on wild-type chromosome, a 10-fold 
increase was observed in the URA3-deficient colony numbers upon the I-SceI induction, suggesting 




Figure 2.2 Synthetic chromosome construction strategy 
A. Minichunk assembly. After restriction enzyme digestion, ~3 kb minichunks (light blue) were assembled 
into ~10 kb chunks (dark blue) using the Gibson assembly method. Each minichunk was designed to 
carry a 40 bp overlapping region with accepting vector (orange) or adjacent minichunks. B. Native 
chromosome replacement with synthetic chunks. On average 5 chunks were used to replace the native 
segments of chromosome II (dark gray). Step-by-step replacements were carried out in parallel from the 
end of the left arm and right arm respectively with iterative selectable markers (LEU2 or URA3) through 
homologous recombination in yeast with homologous regions around 500 bp. ~1 kb junctions (purple) 
produced by PCR using ligated chunks as template were designed to have 500 bp regions overlapping 
with two adjacent chunks to improve the replacement efficiency. C. I-SceI mediated synIIA-R and synIIR-
Y integration. An I-SceI site (red) was introduced on both semi synthetic chromosomes. After mating, I-
SceI induction was performed to generate double strand breaks on both semi synthetic chromosomes. 
30 kb homologous region on both semi synthetic chromosomes enabled the integration of complete 
synthetic chromosome. 
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2.2 Acoustic dispensing technologies mediated nanoliter scale DNA assembly 
To accelerate completion of Sc2.0, the project was decentralized by parceling out the construction of 
individual chromosomes to different teams. Each team is also trying various strategies to further 
facilitate the construction process. However, the construction effort of each chromosome, especially 
for megabase long chromosomes, are still labor-intensive. Take SynVII as example, 435 minichunks 
need to be assembled into 129 chunks, then followed by 25 runs of megachunk integration through 
homologous recombination in yeast. With current synthesis costs for Sc2.0 averaging approximately 
US$0.10 per base pair, the overall cost for just the Sc2.0 DNA is around US$1.25 million. The total 
costs of the project, including labor for assembly, genotyping, sequencing, fitness and phenotypes 
evaluation, debugging and bug corrections, developing and maintaining software and servers, and 
other activities and associated indirect costs will be considerably higher. Therefore, methods that can 
reduce the labor and significantly decrease the cost are much appreciated.  
 
Traditional liquid handling technology has enabled increased throughput of many experimental 
protocols and assays by (1) increasing operational speeds, (2) reducing working volumes (down to a 
microliter range), and (3) reducing the need for error-prone manual handling, and ultimately 
contributed to substantial workflow cost savings. Although a big “leap forward,” the demand for 
further protocol miniaturization continues to increase, particularly in ultra-high-throughput screening 
(uHTS)73. Traditional tips/nozzles-based robotic platforms struggle to precisely dispense liquid 
droplets below the microliter threshold. Pin tools can be used to transfer nanoliter to microliter liquid 
from source plates to destination plates; however, because they are contact based, the pin tools 
usually require washing and drying between transfers to avoid cross-contamination. Also, the 
delivery volume of pin tools is difficult to control as many factors are involved, such as the shape, 
the diameter, and the coating of the pin, as well as the speed of dipping and removing of the pin. 
Finally, pin tools are usually made in 96, 384, and 1536 formats, which limits their flexibility of 
usage, e.g., in setting up different reaction volumes in the same plate. Another technology allowing 
reaction miniaturization is the microfluidic chip technology74. Kong et al. have successfully used 
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microfluidic chips to synthesize DNA sequences up to 1 kb, and Tewhey et al. used microfluidic 
chips to run 1.5 million PCRs in parallel75,76. The main disadvantage of the microfluidic chip 
approach is that the master molds and the control layer need to be custom designed and fabricated 
for different reactions; regardless, the de novo DNA synthesis using microfluidic chips is very 
complementary to the miniaturized assembly methods applied. 
 
First described in 1927, the acoustic droplet ejection (ADE) method utilizes acoustic energy to 
rapidly move low-volume nanoliter to picoliter droplets without any physical contact77. Before it 
reached the laboratory setting in the 2000s, the drop-on-demand technology was first exploited in a 
number of other fields, such as the ink-jet printing industry and pharmaceutical companies. Today, 
Labcyte, Inc. (Sunnyvale, CA) is pioneering the acoustic dispensing technology for Life Sciences, 
with its Echo series robotic platforms being able to transfer multiple 2.5 or 25 nL droplets from the 
384- and 1536-well sources to the various (inverted) destination plates. Unlike traditional robotic 
liquid transfer methods, laboratory acoustic dispensing has been shown to be highly precise at the 
nanoliter volume range (as demonstrated by its low coefficients of variation), thereby enabling 
further miniaturization of current protocols and assays. The acoustic dispenser is flexible enough to 
set up any-to-any configurations between the source plate and the destination plate, and the reaction 
volumes can vary from well to well in the same reaction plate.  
 
Frequently used experiment protocols during the synthetic chromosome construction and verification, 
such as PCR, Gibson assembly, Goldengate assembly, bacterial transformation and PCRTag analysis 
were designed and adapted accordingly to the Echo550 robotic platform. In general, the preliminary 
data is very promising, showing high efficient PCR, assembly and verification can also be achieved 
on nanoliter scale, which would significantly reduce the cost and hold the potential to be further 
automated to reduce the labor dependence. 
 
Echo PCR 
Conventional endpoint PCR is instrumental in making synthetic DNA. To test the minimal volume 
of regular PCR using Echo, PCRs of various volumes was set up. The plasmid HcKan_P vector 
 48 
(concentration at 120 ng/µl) was used as the DNA template, and a pair of primers YCp2214 and 
YCp2215 were designed to amplify a targeted DNA fragment of 1378 bp (Figure 2.3A). Five reaction 
volumes ranging from 50 to 1000 nL were set up, with a manual control at 10µL (Table 2.4). Each 
reaction was performed in four replicates.  
 
 
Figure 2.3 PCR setup by Echo 
A. A pair of primers was designed to amplify a 1.3 kb fragment, and PCRs of various volumes were set 
up by the Echo machine. B. Gel electrophoresis confirms that PCR can work at the 250 nL scale. Gel 
stained with 1× SYBR Safe DNA stain. 
 
We used the Echo machine to set up PCRs in total volumes ranging from 50 nL to 1 µL (Figure 2.3B 
and Table 2.4). Starting from 250 nL, a band of the correct size could be detected by gel 
electrophoresis. Because the PCR product was diluted to 5 µL for gel electrophoresis, it is possible 
that PCRs at 50 nL scale were successful, but the detect by gel electrophoresis was not sensitive 
enough to detect a signal. Alternatively, it would be possible to use the Caliper Labchip GX 
instrument that can detect DNA concentrations as low as 5 ng/µL. Downsizing the PCR from 50 µL 
or higher to 250 nL already effectively cuts the reagent cost by 200-fold. Miniaturized PCR is ideal 
for diagnostic purposes such as fast genotyping and colony-screening PCR, but it is less suitable for 
applications requiring use of the PCR product for downstream procedures, such as cloning, because 




Table 2.4 Echo PCR setup 
 
Gibson DNA assembly 
First described in 2009, the Gibson DNA assembly method5 belongs to a group of overlap-directed 
DNA assembly techniques such as CPEC78, SLiCE79, and SLIC80 assemblies. The Gibson assembly 
method is one of the most used assembly methods in synthetic biology, and it can assemble DNA 
sequences up to small genome sizes from overlapping DNA fragments in an isothermal one-pot 
reaction. The advantages of Gibson assembly include sequence independency and the ability to 
generate scarless final assembled DNA products. Typically, the Gibson assembly requires a ~40 bp 
homologous region between two adjacent DNA fragments, and these homologous regions are usually 
added to the fragments by a high-fidelity PCR. Briefly, the assembly reaction takes place in a cocktail 
of enzymes (termed Gibson master mix) at 50 °C for 60 min: (1) First, T5 exonulease chews back 
the DNA in a 5′ to 3′ direction from the homologous terminal ends to reveal reverse complementary 
single-stranded sequences between two adjacent fragments. (2) While the 5′ to 3′ DNA digestion 
proceeds, a high-fidelity DNA polymerase fills in the single-stranded DNA region. (3) Finally, Taq 
DNA ligase seals the nicked DNA strands, which yields the final assembled product.  
 
Two pairs of primers (YCp2391 and YCp2392 for fragment 1, YCp2393 and YCp2394 for fragment 
2) were designed to amplify two fragments with 40 bp end homology from a red fluorescent protein 
(RFP)–containing plasmid pPC025, thus allowing subsequent Gibson reassembly of the plasmid 
(Figure 2.4A,B). The two homologous junctions were placed within the ampicillin resistance gene 
and the RFP open reading frame (ORF) to reduce the overall false positive rate and to allow 
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phenotypic selection for successful assembly clones isolates, respectively. Here, RFP serves as a 
positive screen for correct assemblies. Four reaction volumes ranging from 50 to 1000 nL were set 
up, with a manual control at 20µL (Table 2.5), and each reaction was performed in triplicate. 
 
Our result shows that Gibson assembly worked extremely well in this setting. Correct assembly was 
observed from as low as the 250 nL reaction volumes, and at 500 and 1000 nL the assembly 
efficiencies are comparable to or better than the manual control, but with notable standard deviations. 
This would result in cutting the reagent cost by 20-fold or more (Figure 2.4D). Even more 
encouraging, no background was observed (Figure 2.4C) and 100% correct assembly through Sanger 
sequencing across the assembly junctions, and this will be highly beneficial for future automation 




Figure 2.4 Gibson assembly reaction setup by Echo 
A. The pPC025 plasmid was split into two overlapping fragments in the middle of the ampicillin resistance 
gene and the RFP ORF. Two fragments were generated with 40 bp overlap at both ends and then 
assembled by the Gibson assembly reaction. B. Gel electrophoresis confirms the successful PCR 
amplification of both fragments. Gel stained with 1× SYBR Safe DNA stain. C. Successful Gibson 
assembly product gives rise to red bacterial colonies. The assembly efficiency was high and no 
background colonies (white) were observed. Negative control reactions, which had only one fragment in 
the reactions, yielded no colonies. D. Cost-effectiveness and assembly efficiency comparison of different 




Table 2.5 Gibson Assembly Reactions 
 
Golden Gate assembly  
The Golden Gate DNA assembly method utilizes a combination of a TypeIIS restriction enzyme and 
a ligase to assemble the DNA fragments81. TypeIIS enzymes (e.g., BsaI and BsmBI enzymes) are 
endonucleases that cut outside their recognition sites, creating 4 bp DNA overhangs. By carefully 
designing the 4 bp overhangs, one can use the Golden Gate reaction to directionally assemble DNA 
fragments. The Golden Gate DNA assembly reaction starts with a given TypeIIS endonuclease DNA 
digestion, leaving behind staggered cuts in the backbone and the fragment DNA. The design-imposed 
DNA complementarity allows annealing of the resulting “sticky ends,” creating the desired plasmid 
construct. In the final reaction step, the T4 DNA ligase repairs the nicks to complete the DNA 
construction phase.  
 
In this study, the HcKan_P plasmid (2.8 kb) was used as the acceptor vector. This plasmid carries a 
KanR selectable marker, along with a RFP cassette flanked by a pair of outward-facing BsaI sites. 
The promoter pMBP1 (500 bp) was amplified directly from yeast BY4741 (MATa, leu2Δ0 met15Δ0 
ura3Δ0 his3Δ1) genomic DNA with primers YCp2395 and YCp2396 and added a pair of inward-
facing BsaI sites to flank the promoter part (Figure 2.5A,B). The 4 bp overhangs were designed in 
such a way that the promoter can be efficiently assembled into the acceptor vector. Bacteria carrying 
the residual RFP plasmid will give a bright red fluorescence, which would facilitate the visual 
identification of correct assembled clones (white colonies; Figure 2.5C). Five reaction volumes 
arranging from 50 to 1000 nL were set up (Table 2.6), and each reaction was performed in triplicate. 





Figure 2.5 Golden Gate assembly setup by Echo 
A. A promoter pMBP1 was amplified from the yeast genome to add appropriate Golden Gate sequences 
(BsaI recognition sites + 4 bp overhangs). The acceptor vector HcKan_P plasmid carries a RFP cassette, 
which is flanked by corresponding Golden Gate sequences to uptake the pMBP1 part in the Golden Gate 
reaction. B. Gel electrophoresis indicates successful amplification of pMBP1. Gel stained with 1× SYBR 
Safe DNA stain. C. Left: Successful assembled DNA gives rise to white colonies, while the residual 
acceptor vector yields red colonies. Right: Negative control, which contained only the acceptor vector in 
the Golden Gate reaction, yielded only red colonies. D. Cost-effectiveness and assembly efficiency 
comparison of different reaction volumes for Golden Gate assembly. 
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With Golden Gate assembly, DNA was successfully assembled in a 50 nL reaction volume (typically 
15 µL reactions when performed manually), and at the 250 and 500 nL scales the assembly 
efficiencies were found higher than those of the manual control. This would lead to at least a 30-fold 
reduction in reagent use when performing Golden Gate reactions using Echo (Figure 2.5D). Uncut 
vector background in the assembly was observed (red colonies, as shown in (Figure 2.5C). There are 
several ways to overcome this. First, instead of using RFP for screening, we can use the toxic ccdB 
gene, which cannot give rise to background colonies in a nonpermissive transformation host. Second, 
we can add a higher concentration of the BsaI enzyme in the Golden Gate master mix to further digest 
the residual acceptor vector. Finally, we may be able to reduce the background by extending the BsaI 
digestion step in the incubation. 
 
  
Table 2.6 Golden Gate Assembly Reactions 
 
In general, our preliminary data shows nanoliter PCR and DNA assemblies can be as equally efficient 
as manual reaction volumes. With further optimization, it should be possible to downsize the reaction 
volume even further. For instance, in this study, individual reaction components were transferred to 
the destination well one by one (in the case of 50 nL PCRs, only 1 droplet of primer was shot), and 
it is possible that some reagents were not properly added to the reaction pool due to slight 
misalignment of the acoustic dispenser. In this case, it would be advantageous to premix as many 
reaction components as possible and then transfer more droplets altogether. We also suggest 
dispensing the master mix using a bulk dispenser or liquid handler, so that the destination well has a 
larger liquid surface to uptake the incoming droplet and minimize chances for the droplets hitting the 
well wall. It is always good practice to centrifuge the PCR plate when appropriate before putting it 
into the PCR thermal cycler to start the reaction. To prevent the nanoliter droplet from evaporating 
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before the reaction starts, we always preheat the PCR machine before putting in the reaction plate. 
Finally, it is more economical to use low-dead-volume plates as the source plate for expensive 
reagents such as enzymes and polymerases. 
 
qPCRTag assay of wild type (BY4741) and SynII 
One of the important design feature of Sc2.0 is the introduction of PCRTags, which are short, 
synonymously recoded sequences within the ORFs that enable differentiation of synthetic 
chromosomes from their wild type counterparts. The standard readout of PCRTag assay is to identify 
the presence or absence of PCRTag amplicons by agarose gel electrophoresis. However, there will 
be over 8000 PCRTags in the final complete Sc2.0 genome, a high throughput and easy handling 
approach is necessary. The method of Mitchell, et al. has improved PCRTag genotyping by 
developing a real time PCR-based detection assay (qPCRTag assay) 82. Echo was used to distribute 
qPCR mastermix, template DNA and PCRTag primers into each well of a 1536 multiwell plate. Then 
a qPCR thermal cycler was used to miniaturize reactions at 500nL scale and maximize throughput. 
And both steps can be further automated. Here in this study, this improved method was tested and 
applied using 768 pairs of wild type and synthetic chromosome II PCRTag primers. Primers were 
arrayed identically in each quadrant of the multiwall plate for easy visual comparison.  
From our result, for the most part, amplification was as expected, whereby synthetic primers 
exclusively amplified synthetic DNA and vice versa (Figure 2.6). However, we also observed several 
deviations from the expected pattern, suggesting false negatives and false positives. In all false 
negative results observed, 10 of the 11 are known to fail due to unspecific amplification or primer 
dimers (Figure 2.7). The remaining one is showing undetermined feedback, which could arise from 
a lack of transfer of mastermix or gDNA template. Overall, our result shows a relative low false 
positive and false negative rate, and careful parameter optimization will help to further eliminate 




Figure 2.6 Plate heat map displaying presence/absence call for SynII qPCRTag analysis 
Two different types of genomic DNA were subjected to PCRTag analysis using synthetic (SYN) and wild 
type (WT) chromosome II PCRTag primers. BY4741 and SynII encode wild type and synthetic 
chromosome II, yielding amplification with WT PCRTag primers and SYN PCRTag primers respectively 
(Green: positive; Red: negative; Yellow: undetermined, signal did not resemble a sigmoidal amplification 
curve).  
 
2.3 Building 770-kilobase SynII 
The sequence of native Saccharomyces cerevisiae chromosome II was determined over two decades 
ago. This native chromosome is 807,888 bp in length and includes 410 open reading frames, 13 
tRNAs, and 30 introns83. SynII was designed based on the native chromosome II following previously 
reported rules introduced in Chapter One, resulting in a “designer” chromosome 770,035 bp in length, 
43,149 bp shorter than the native sequence. SynII was initially synthesized as minichunks (~3 kb), 
assembled into chunks (~10 kb) and integrated into the yeast genome to replace the native 
chromosome. The construction was done previously by the team from BGI. The resulting strain was 
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identified by the PCRTag method. PCRTags are pairs of ~20bp synonymously recoded segments of 
the coding region of ORFs. Most ORFs are incorporated with PCRTags, with one PCRTag per ORF 
on average. Therefore, after each run of synthetic DNA integration, pairs of wild type and synthetic 
PCRTags in that corresponding region can be used to quickly scan to ascertain whether a complete 
substitution has occurred. Here, PCRTag analysis confirmed the complete construction of SynII 
(Figure 2.7, Figure 2.8). Although PCRTags can help easily identify the presence of synthetic 
segment, they cannot distinguish any structure variations such as inversion or duplication. Therefore, 
whole genome sequencing using the Ion PGM™ sequencing platform (Life Tech) was performed to 
further verify SynII strain.  
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Figure 2.7 SynII full PCRTag analyses 
The presence of synthetic PCRTags and absence of wild-type PCRTags indicate the successful 
replacement of native sequence by synthetic sequence. Red asterisk: amplification failure of synthetic 
PCRTags, which might be caused by PCRTag design failure or PCR failure. Blue asterisk: PCRTags 
that can amplify both synthetic and wild type genome, which were found to be homologous regions on 
other chromosomes.  
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 [Figure 2.7 SynII full PCRTag analyses - Continued] 
 
Figure 2.7 SynII full PCRTag analyses 
The presence of synthetic PCRTags and absence of wild-type PCRTags indicate the successful 
replacement of native sequence by synthetic sequence. Red asterisk: amplification failure of synthetic 
PCRTags, which might be caused by PCRTag design failure or PCR failure. Blue asterisk: PCRTags 
that can amplify both synthetic and wild type genome, which were found to be homologous regions on 
other chromosomes.  
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Figure 2.8 BY4741 full PCRTag analyses 
The presence of only wild type PCRTags amplicons means high specificity of both synthetic and wild 
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Figure 2.8 BY4741 full PCRTag analyses 
The presence of only wild type PCRTags amplicons means high specificity of both synthetic and wild 




2.3.1 Whole genome sequencing revealed structural variations in SynII 
In total, 455M bp clean ~400bp reads, with 37.6-fold sequencing depth of the genome were generated 
(Figure 2.9). Clean reads were mapped to BY4741 and BY4742 yeast reference sequences (the 
wildtype sequence of chromosome II is replaced by synthetic chromosome II sequence) using 
bowtie2-2.0.084 with standard settings. For each alignment result, local realignment was performed 
with GATK 2.7-285 RealignerTargetCreator and IndelRealigner tools to clean up mapping artifacts 
generated during reads mapping on the edges of indels. The resulting files with BAM format were 
then prepared for variation calling.  
 
 
Figure 2.9 Statistics of SynII Ion PGM™ sequencing reads 
A. Length distribution of filtered read generated from Ion PGM™ Sequencing platform. B. Quality 

































































Compared with the designed sequence, 61 variations of 4 types were observed by deep sequencing: 
50 single nucleotide variations (SNVs), 5 missing loxPsym sites, 4 deletions and 2 structural 
variations (SVs) (Table 2.7). 28 of the 50 SNVs were found to correspond exactly to the genotype of 
the native chromosome sequence at these positions, suggesting that these represent residual 
homologous recombination “patchworks” as seen in SynIII and other synthetic chromosomes16,17,19-
22. When such patchwork regions are short (i.e. lying entirely between two sets of PCRTags), they 
can be missed by the PCRTag analysis. For the remaining 22 SNVs, 3 were found to pre-exist in 
synthetic minichunk DNA indicating that these mutations were introduced during synthesis. The 
remaining SNVs map to overlapping regions between minichunks or megachunks, suggesting that 
these SNVs were likely introduced during minichunk assembly or megachunk integration. Since none 
of these SNVs were in coding regions or noticeably altered phenotype, they were not corrected.  
 
As previously seen in other larger synthetic chromosomes (SynV, SynX) 19,21, two complex structural 
variants (SVs) were observed:  one was a ~15 kb tandem-duplication in megachunk L with chunk 
L2-L4 duplicated and a loxPsym site located between the duplications (Figure 2.10A,B); the other 
SV, identified in megachunk T, was fully characterized by PGM sequencing (Life Technologies), 
and is a >30 kb complex DNA sequence including multiple copies of chunks T4, T5 and a partial 
chunk backbone plasmid pSBGAK (Figure2.10C,D). We hypothesize that the 34 bp loxPsym 
sequence can serve as a homologous region during homologous recombination-mediated integration, 
albeit at a very low frequency, which led to the formation of the first SV. The mechanism of formation 
of the second SV remains unknown. 
 
2.3.2 Correction of structural variants in SynII 
We designed a straightforward strategy to repair the two structural variations, again by applying the 
I-SceI system86. The 18bp I-SceI recognition sequence was designed to carry a selective marker 
(URA3) and overlap with both ends of the tandem repeat junction as a donor fragment (Figure 2.11A). 
Upon induction of I-SceI digestion, the SynII chromosome was broken and thereafter repaired 
through homology-directed recombination between the repeat sequences, and as a consequence 
duplicated region was effectively looped out.  
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Using this strategy, the two SVs in synthetic chromosome II were sequentially repaired, yielding 
strains yeast_chr02_9.02 and yeast_chr02_9.03 respectively (Figure 2.11B). PCR analysis (Figure 
2.10D) and deep sequencing (Figure 2.11C) validated the successful repair of the duplicated regions 
in SynII. Duplications were also observed in other synthetic chromosomes (SynV, SynX, SynXII). 
Thus the I-SceI method could serve as an efficient strategy for repair of large duplications during 
synthetic chromosome construction.  
In addition to the SVs, pulsed field gel analysis (PFGE) revealed an abnormal karyotype of native 
chrXIII and chrXVI (Figure 2.12). This was further confirmed by DNA sequencing and Hi-C 
analysis87. As similar instances have also been found during the construction of SynIII17, we surmise 
that this represents a spontaneous low-frequency event occurred at some point during assembly. 
PFGE shows that the chrXIII and chrXVI karyotype of the SynII strain with SVs (yeast_chr02_9.01) 
is correct. We repaired this chromosomal crossover by first switching the mating type of the repaired 
SynII (yeast_chr02_9.03) and then back crossing to SynII strain (yeast_chr02_9.01) to avoid 
crossover between synthetic chromosome II and native chromosome II. After tetrad dissection, the 












Figure 2.10 SynII structure variation identification and repair verification 
A. Full sequence map of SynII. B. Putative tandem duplication at megachunk L. Duplicated regions are 
depicted in yellow. C. Complex duplication at megachunk T. pSBGAK is the clone vector of chunk T5; 
T5_wt_hom are the wild-type homologous sequence on chunk T5. LEU2-1 (398 bp) and LEU2-2 (1399 
bp) are upstream and downstream sequences of LEU2, respectively. Numbers are the breakpoints 
identified by sequencing. D. PCR at each identified breakpoint in the SynII strain was performed before 
and after structure variation repairing to identify the exclusion of duplicated regions. Sizes of amplicon 
products at each breakpoint are shown. 
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Figure 2.11 Structure variation repair through chromosome breakage 
A. I-SceI mediated repair strategy for SynII structure variations. The donor fragment was designed to 
carry a URA3 cassette (yellow) and I-SceI recognition site (organge), with both ends overlapping the 
structural variation sequences observed in SynII (yeast_chr02_9.01). The donor fragment was integrated 
into SynII between the two tandem repeats through homologous recombination, then an episomal 
plasmid pRS413-pGal1-I-SceI was transformed into the cell. A double strand break at the I-SceI site was 
induced in galactose medium, and the homologous recombination of two partial chromosomes of SynII 
eliminated the duplication. B. Structure variations in megachunks L and T and their corresponding donor 
sequence design. In megachunk L, a copy of chunk L2-L4 was observed following the original L2-L4 
sequence that generated a tandem-duplication. The donor fragment was inserted directly between two 
duplications. In megachunk T, the donor fragment was inserted to remove the complex variation with 
multiple copies of chunks T4, T5 and a partial chunk backbone plasmid pSBGAK sequence. C. Deep 
sequencing read depth analysis revealed the successful sequential removal of duplications. The starting 
synthetic chromosome SynII (yeast_chr02_9.01) has both duplication regions, and after the first round 
of repair at megachunk L, the resulting chromosome SynII (yeast_chr02_9.02) shows only one 
duplication. The finished chromosome SynII (yeast_chr02_9.03) was obtained after the second repair at 
the megachunk T region.   
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Figure 2.12 Karyotype analysis of SynIIA-R, SynIIR-Y, SynII with duplications, repaired SynII 
strains by PFGE 
SynIIA-R (strain ID: YS018) and SynIIR-Y (strain ID: YS026) are the two semi-synthetic SynII strains 
used for constructing the full synthetic SynII, named SynII (yeast_chr02_9.01, strain ID: YS029). SynII 
with one of the two duplications repaired is named as SynII (yeast_chr02_9.02, strain ID: YS030), 
followed by the final repaired SynII (yeast_chr02_9.03, strain ID: YS031) and strain with complete SynII 
and rearrangement between chromosome 13 and 16 repaired SynII (yeast_chr02_9.03, strain ID: 
YS033). Chromosome numbers are labeled on the right side. The final SynII strain shows no karyotype 
abnormality compared to the BY4741 and BY4742 strains. Triangle in the figure shows abnormal 
karyotype comparing to native strains. 
 
At this point, the full construction of SynII was completed and its genotype was carefully verified. 
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2.4 Building 1015-kilobase SynVII 
Among the total 16 chromosomes, chromosome VII is one of the four chromosomes larger than 1Mb. 
It has 572 predicted ORFs, of which 341 are uncharacterized88. Of the ORFs, 17% show high 
similarity to human genes, compared to the 31% similarity to humans on whole genome scale71. 
Almost half of the ORFs could be classified into functional categories, while the number on the whole 
genome scale is 43%71,89. The number of tRNAs located on chromosome VII is 36, which is the 
highest among all chromosomes and the interplay between the synthetic chromosome VII and the 
tRNA neochromosome (part of Sc2.0 project) will be very interesting to study as well.  
According to the three design principles (1. do no harm, 2. maintain genomic stability and 3. increase 
genetic flexibility), several changes have been made on chromosome VII: Telomeres are replaced by 
artificial telomeres of the simple sequence repeat (TG1-3)n. 14 introns and 60 retrotransposons are 
deleted. All 36 tDNAs on chromosome VII are removed and will be placed on the “neochromosome”. 
706 pairs of PCR tags are added in synthetic chromosome VII to distinguish it from natural 
chromosome. 316 loxPsym sites are added in the 3’UTR region of each non-essential ORF in 
chromosome VII for SCRaMbLE. For the total of 127 TAG stop codons on chromosome VII, 126 are 
swapped to TAA. One TAG was retained as the change might affect an overlapping ORF. The final 





Figure 2.13 SynVII design 
Native telomere sequence is replaced by synthetic telomere. 14 introns and 60 retrotransposons are 
excluded. 36 tRNA genes are relocated to tRNA neochromosome. 126 stop codons are swapped from 
TAG to TAA. 706 pairs of PCR tags are added into SynVII for distinguishing from natural chromosome 
VII. 316 loxPsym sites are designed evenly distributed in SynVII for SCRaMbLE. 
 
The sequence of synthetic chromosome VII is computationally segregated by BGI customized 
software “Segman” to 25 50kb-megachunks, then to 129 10kb-chunks and to final 485 3kb-
minichunks the synthesis of which was directly outsourced to a DNA synthesis company. In addition, 
chromosome VII was finished with efforts from both UK and China, under the collaboration between 
UoE and BGI. SynVIIL (carrying Megachunk A-N) was constructed by team of BGI, while SynVIIR 
(carrying Megachunk O-Y) was assembled in Edinburgh. Then SynVIIL and SynVIIR carrying I-SceI 
sites were combined to generate the fully synthetic SynVII. 
 
PCRTag assay 
The flexibility to analyze and quantify the synthetic content of the genome is important throughout 
the expanded genome synthesis process. For SynVIIR, 288 WT PCRTag primer pairs and 288 SYN 
PCRTag primer pairs are used for PCRTag assay during synthetic megachunks integration. PCRTag 
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assays of wild-type yeast (BY4741) gDNA showed the presence of only wild-type PCRTags, 
demonstrating the specificity of all wild-type PCRTag primers (Figure 2.14). However, 4 synthetic 
PCRTags gave a positive signal of wild type gDNA. Sequence of these primers were aligned to 
BY4741 genome reference with BLASTN, with 3' end mapping (>10bp and only 3bp mismatches at 
3' end) been considered as possible binding sites. The alignment showed that these primers cannot 
align to other locations on the genome, indicating the design should be correct. Therefore, these 
primers were re-synthesized to exclude the possibility that amplification might be caused by 
mutations on these primers. Analysis confirms that the presence of these synthetic PCRTags is caused 
by mutations on primers introduced during synthesis (Figure 2.15A). For wild-type PCRTags, only 
one wild-type PCRTag primer pair, namely WT_chr07_T1_3_F and WT_T1_3_R, did not yield any 
product under the PCR conditions used for PCRTag assay. Re-design of this primer was performed 
by reducing the length from 28bp to 23bp without changing the binding site. Subsequent analysis 
shows that with new designed primers, WT_chr07_T1_3 PCRTag is present and can be used to 
rapidly verify the introduction of synthetic sequence and removal of native wild-type yeast 




Figure 2.14 PCRTag assay of wild-type gDNA (BY4741) 
Partial PCRTag assay of wild-type yeast (BY4741) gDNA showed the presence of WT PCRTags and 
absence of SYN PCRTags. Two SYN PCRTags, syn-O1-1 and syn-P2-6 are present, demonstrating it 
is either caused by the errors created by the gene synthesis company and lead to unspecific amplification. 
 
 
SynVII synthesis and assembly 
The full SynVII sequence is segregated into ~3kb minichunks or 10kb chunks for de novo DNA 
synthesis. The nomenclature of minichunk uses the following naming convention: minichunk is 
named with Chunk ID followed by “HoM”, “Ho” or “Fx”. “HoM” refers to the homologous region 
between megachunks; “Ho” means the homologous region between Chunks and assembly accepting 
vector, while “Fx” indicates the x fragment. Each minichunk is designed with a 40bp overlapping 
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region on both sides to enable efficient chunk assembly via in vitro Gibson assembly strategy5. For 
chunk assembly, the strategy used for SynIII was to ligate each chunk first and then transform them 
into yeast for integration via homologous recombination17. However, for chromosome VII, an 
alternative strategy was applied: each chunk is designed to have an 800bp-1200bp homologous 
region, and the ligation step was skipped by directly transforming all 5-6 chunks (equal to 1 
megachunk) into yeast for integration.  
For megachunk O, Q, S, U, W, X and Y, chunk assembly from corresponding ~3kb minichunks is 
required. The old strategy includes three steps: first, digesting out the minichunk fragment from 
corresponding carrying vector; second, Gibson assembly and bacterial transformation; and third, 
verifying by miniprep and digestion. However, efficiency of each Gibson assembly varies for several 
reasons, such as the number of DNA fragments, the length and potential secondary structure of 
overhangs. And normally for a chunk assembly, miniprep and digestion of 10 to 20 colonies is 
required in a single run in order to find the correct construct. Here, the workflow is refined by adding 
one additional step of colony PCR to reduce the cost and unnecessary workload (Figure 2.15). Two 
sets of primers are designed for the accepting vector and chunk sequence. A successfully assembled 
chunk will have both amplicons with sizes of ~300-800bp that cover the junctions of accepting vector 
and chunk sequence. And usually 80% of assembled products showing both bands are found to be 
correct following verification by digestion. By doing so, more colonies can be screened for each 
chunk assembly (~24 colonies on average), while much less work of miniprep and digestion is needed 
(2-4 on average). This single added step increases the chance to find correct chunk assembly product 
and significantly reduces the cost of reagents and consumables. By applying the refined workflow, 




Figure 2.15 Refining chunk assembly workflow by adding a colony PCR step 
Two sets of primer pairs, VF primer set and VR primer set, are designed to amplify junctions between 
accepting vector and chunk sequence and used for colony PCR. Colony is first dipped into PCR master 
mix, followed by dipping into corresponding well of a 96-deep well plate for overnight culture. After 
verification by gel electrophoresis, colonies with both positive bands are further verified by digestion.  
 
Minichunk and Chunk fingerprinting 
For minichunks/chunks that were outsourced to a DNA synthesis company (Life Tech), a major issue 
discovered so far was unwanted mixing of different minichunk samples. Take Y4Ho minichunk as 
an example, repeated failure of Y4 chunk Gibson assembly was experienced without a reasonable 
explanation. Once sent for sequencing, it was realized that the sequence was aligned to a region in 
megachunk A. After further investigation, the minichunk used for chunk Y4 Gibson assembly is 
actually A4Ho, which was from the same batch sent for synthesis with Y4Ho. Therefore the only 
plausible explanation was that the DNA synthesis company mixed up the samples in the same batch. 
And failure of discovering this issue earlier, in part, was due to the similar size after digesting out 
these minichunks from the accepting vector. Therefore, a QC process called “Plasmid Fingerprinting” 
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is included to verify all minichunks/chunks outsourced for synthesis. Instead of using restriction 
enzymes designed to digest out minichunks/chunks, 1-2 restriction enzymes with multiple sites 
present in each minichunk/chunk plasmid were used to cut the plasmid into 3-8 pieces such that most, 
if not all, fragments are small enough to be accurately sized by again gel electrophoresis, generating 
a very unique pattern that will distinguish each minichunk/chunk plasmid.  
A computer program was developed to automatically analyze the multiple cutter sites for each sample, 
which generates a spreadsheet containing information such as list of multiple cutter enzymes, number 
of fragments and corresponding sizes after digestion. In total 132 minichunks and 19 chunks, only 
two minichunks, namely Y2F3 and W2F3, failed to pass the fingerprinting QC. Sequencing of W2F3 
minichunk again confirms that this sample is mixed up with other minichunks. Further investigation 
of the Y2F3 minichunk is discussed in the following “Problematic Minichunk troubleshooting” part. 
The DNA synthesis company has been contacted to further verify these two samples and requested 
to send correct products. In summary, “Plasmid Fingerprinting” is highly recommended as an 
efficient QC method, especially for high throughput DNA synthesis platform. 
 
Problematic minichunk trougbleshooting 
During the chunk Y2 assembly, an aberrant digestion result was noticed during minichunk digestion. 
According to gel simulation, the size of target Y2F3 minichunk should be 2639bp. However, the 
result from gel electrophoresis showed a band over 3kb (Figure 2.16A). A repeat digestion was 
performed and further confirmed that this was not due to experimental error. To further investigate, 
successive Primer walking was performed to verify the sequence of Y2F3 minichunk. Two primers 
that matched the beginning and the end of target Y2F3 minichunk sequence, namely 
Y2F3_sequencing_F and Y2F3_sequencing_R, were designed for first run of sequencing. Then each 
end of the sequenced strand was used as a primer (Y2F3_sequencing2_F and Y2F3_sequencing2_R) 
for the next run of sequencing. That way, the short part of Y2F3 minichunk that was sequenced kept 
“walking” along the target sequence. After 2 runs of primer walking, a 777bp sequence was 
confirmed to be inserted into Y2F3 minichunk, which was not consistent with the sequence design. 
The insert was further analysed by aligning its sequence to that of the plasmid and found it could be 
partially aligned to the plasmid backbone at bacterial ColE1 origin sequence (Figure 2.16B). These 
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data showed that the Y2F3 minichunk construct received from DNA synthesis company was 
incorrect, therefore, resynthesis of this minichunk was performed. 
 
 
Figure 2.16 Digestion and sequencing verify of Y2F3 minichunk 
A. Digestion result of the Y2F3 minichunk shows a band ~1kb larger than predicted (Arrow pointed). B. 
Two sequential runs of sequencing confirmed a 777bp insert (blue box) within target Y2F3 minichunk 
sequence, which can be partially aligned to the ColE1 origin sequence in the plasmid backbone. 
 
The synthesis of minichunk Y1F1 (3433bp in size) failed repeatedly by the outsourced company. 
The best they could provide were two constructs carrying the full length of Y1F1 fragment, but each 
of them harbored a non-synonymous point mutation (T mutated to C at 775bp, Ser to Ile; G mutated 
to T at 1234bp, Met to Thr, repectively). The reference sequence contained in Saccharomyces 
Genome Database (SGD) shows that there are three ORFs in this minichunk: YGR275W, YGR276C 
and YGR277C (Table 2.8). Both point mutations were found in YGR276C coding region, indicating 
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that this gene might be toxic to E. coli during cloning, which may explain why it is hard to obtain a 
colony carrying 100% correct Y1F1 fragment sequence.  Therefore, an alternative strategy was 
designed: Y1F1 was split into two pieces Y1F1-A & Y1F1-B, each of them contained a ~500bp 
overlap region. Y1F1-A was assembled with upstream minichunks to generate Y1-A intermediate 
chunk, and Y1F1-B was assembled with downstream minichunks to generate Y1-B intermediate 
chunk (Figure 2.17). Then Y1-A and Y1-B were combined with other chunks (Y2, Y3, Y4 and Y5) 
for the megachunk integration through homologous recombination.  
 
 
Table 2.8 Mutation information of two Y1F1 constructs 
 
 
Figure 2.17 Design of Y1F1-A and Y1F1-B construction 
Primers are designed to amplify Y1F1-A and Y1F1-B separately. A 40bp overlapping sequence on the 
primers is included to facilitate the assembly of Y1F1-A and Y1F1-B separately with other minichunks. 
For Y1F1-A, the 35bp forward primer is designed to fully align to the template, while the 82bp reverse 
primer has 36bp sequence that can align to the template and 46bp tail that overlaps with the 5’ end of 
linear vector; for Y1F1-B, the 86bp forward primer has 40bp sequence that can align to the template and 
46bp tail that overlaps with the 3’ end of linear vector, while the 42bp reverse primer can fully align to the 




Three attempts were tried to construct Y1F1-A and Y1F1-B fragments with TOPO cloning and pJET 
cloning with several different pairs of primers. For Y1F1-A, results show that Y1F1-A could not be 
obtained from cloning and bacterial transformation. Sequencing results show that all constructs 
obtained were either partial sequence or rearranged sequence. Similar results were also observed 
during Y1F1-B construction. In conclusion, generating Y1F1-A & Y1F1-B by PCR and TOPO/pJET 
cloning in Dh5α competent cell or 5-alpha F'Iq Competent E. coli competent cell was not successful, 
likely due to the toxicity to bacteria used. 
Since Y1F1 minichunk sequence is originally from BY4741 yeast, it is possible that repaired 
fragment could be obtained by yeast transformation. Therefore, Multichange ISOthermal (MISO) 
mutagenesis90 was applied to fix the single nucleotide mutation in Y1F1 construct. The pRS413 
plasmid was used as the accepting vector and template for PCR. Two pairs of primers carrying the 
corrected base at the mutation site were used to amplify two fragments from the Y1F1 mutant #1, a 




Figure 2.18 Design of Y1F1 MISO 
Two pairs of primers carrying the correct base at the mutation site were used to amplify two fragments 
(one with the size of 1257bp and the other with the size of 2224bp) with 40bp overlapping regions on 
both sides from the Y1F1 mutant #1. SmaI digestion was performed to linearize pRS413 plasmid. Then 
the three fragments were assembled through yeast transformation. 
 
Instead of Gibson assembly and bacterial transformation, yeast transformation was applied to 
assemble the three pieces of DNA, with pRS413 plasmid as the positive control and ddH2O as the 
negative control for yeast transformation (Figure 2.19A). Then the two sets of PCR primers used to 
amplify the two fragments of Y1F1 were used again for colony PCR verification. The result gel 
shows that Y1F1 was successfully assembled in pRS413 plasmid (Figure 19B). In addition, pRS413-
Y1F1 construct was isolated from yeast and re-transformed into bacteria to further verify whether 
Y1F1 minichunk is toxic to bacteria. After re-transform back to E. coli (Dh5α), colonies were only 
observed in positive control plate, confirming that the Y1F1 minichunk was toxic to E. coli (Figure 
 80 
2.20). Therefore, an alternative strategy was applied to integrate the synthetic megachunk Y in 
BY4742 initial strain to replace the wild-type Megahunk Y. Considering the high efficient 
homologous recombination mechanism in yeast, here I propose that minichunks can be used directly 
for integration as each minichunk carries 40bp overhangs (Figure 2.22A). These results show that 
one colony was obtained with all synthetic fragment integrated at the designated site (Figure 2.21B).  
 
 
Figure 2.19 Yeast transformation and verification of Y1F1 MISO 
A. Yeast transformation of Y1F1 MISO. From left to right, yeast transformation of Y1F1-MISO product, 
yeast transformation of pRS413 as positive control, yeast transformation of ddH2O as negative control. 





Figure 2.20 Bacterial transformation of pRS413-Y1F1 plasmid 
Upper, from left to right, bacterial transformation of colony PCR verified pRS413-Y1F1 construct B1, B2, 
B5, and B6. Lower, from left to right, bacterial transformation of colony PCR verified pRS413-Y1F1 





Figure 2.21 Integration of Megachunk Y 
A. Minichunks of chunk Y1 and Y2, together with chunk Y3, Y4 and Y5 are digested out and mixed with 
chunks directly for integration. B. PCRTag verification of integration products. Presence of synthetic 
PCRTags and absence of wild-type PCRTags indicate the successful substitution of synthetic 
megachunk Y. 
 
Another problem during integration was also experienced: substitution of Megachunk W was very 
challenging due to repeated failures. After several runs of attempts, the best construction obtained 
was one strain carrying a partial wild-type sequence: a ~10kb region junction chunk W4, W5 and 
 83 
W6 (Figure 2.22). This implies some Sc2.0 design elements within the wild-type region could be 
responsible for the integration failure. Considering the troubleshooting could be a very time-
consuming process, the strain carrying partial wild-type sequence in Megachunk W was used for 
further construction, while troubleshooting was performed in parallel (details explained in Chapter 
Three). Once the problem is identified, repair can be performed on the final strain to obtain the final 
construct.  
 
As a result, the constructed SynVIIL and SynVIIR were combined through the same strategy used for 
SynII, generating the full SynVII chromosome.  
 
2.4.1 Sequencing and correction of variants in SynVII 
Compared with the designed sequence, Sequencing of the SynVII strain revealed 88 SNVs, 2 
insertions, 6 deletions, and the partial wild-type region in Megachunk W (Figure 2.23, Table 2.9). 20 
of the 88 SNVs were found to correspond exactly to the genotype of the native chromosome sequence 
at these positions, in agreement with the observation in SynII and other chromosomes. 29 SNVs 
found in intergenic regions were likely introduced during assembly and integration. One base 
insertion was found in YGR076C gene, which encodes large subunit of the mitochondrial ribosome91.  
A frameshift mutation in this gene might cause respiratory deficiency, which is also consistent with 
the growth defect observed. Therefore, this particular variation needed to be repaired, and details are 




Figure 2.22 Sequencing revealed a missing loxP site and a wild-type region in Megachunk W of 
SynVII 
A wild-type region in megachunk W was identified after sequencing verification, The ~10kb region 
contains the partial coding region of YGR252W and YGR258C, and ORFs of YGR253C, YGR254W, 




Table 2.9 Variants in SynVII strain revealed by sequencing data 
Synonymous SNVs are not shown in this table. 
 
 86 
The repair of the remaining wild-type region of megachunk W showed significant phenotypic defect 
(details discussed in the next chapter), suggesting potential design flaws that need to be eliminated 
from SynVII. Apart from this, the full construction of SynVII at this point can be considered 
accomplished.  
 
2.5 Conclusion and discussion 
In the first part of this chapter, we demonstrated that nanoliter PCR and DNA assemblies were 
designed and successfully tested using the Echo robotic platform. As the continual efforts are being 
conducted by the Sc2.0 consortium for other to-be-finished chromosomes, this method can 
significantly help to save the cost as well as reduce the labor. In the world of laboratory automation, 
efficiency and robustness are as important as cost-effectiveness. With this in mind, we overlaid a 
number of correct assemblies (efficiency) with standard deviation (robustness) in the same plot with 
the cost of reactions for the Gibson assembly (Figure 2.4D) and the Golden Gate assembly (Figure 
2.5D). The intersections of the two curves indicate the “sweet spots” for choosing desired reaction 
volumes, which are of high efficiency, low standard deviation, and relatively low cost. It should be 
noted that our cost calculation did not take into account the dead volume of reagents, and logically it 
can be assumed that the dead-volume cost per reaction would decrease as more reactions are set up 
by Echo in one experiment. Whenever possible, low-dead-volume plates should be used for 
expensive reagents to save cost. Conversely, we did not include the tip cost in the manual control 
experiments, which increase substantially when the number of reactions is scaled up. Continuously 
monitoring DNA assembly efficiency along with the assembly cost is critical to successful operation 
of a large DNA synthesis and assembly automation facility, such as the UK DNA foundries. The 
acoustic dispensing has great potential in automating other molecular biology operations. We also 
used the Echo to purify single colonies from bacterial and yeast cultures, which is traditionally 
challenging to automate. As Echo is capable of dispensing nanoliter droplets with high precision, it 
is also ideal for generating high-density assembly libraries through combinatorial assembly methods. 
In conclusion, the work described here is the first report on the use of the acoustic dispenser in 
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synthetic biology, and we envision that this technology will be instrumental in lab automation, in 
particular in the era of DNA foundries. 
In the second part of this chapter, the design and construction efforts were explained in detail. SynII 
and SynVII were constructed from both ends. Other innovative approaches with the goal of 
parallelized construction are possible. SynXII was constructed in 6 parallel production strains (a 
method termed Meiotic Recombination-mediated Assembly), which can further promote the 
construction efficiency22. Future efforts combining both approaches for developing a more efficient 
construction method can be envisioned. Compared to SynII, the construction of SynVII seems to be 
more challenging. The failure with the Minichunk assembly of Y1F1 and the substitution of 
Megachunk W indicate that some previously unrealized biological properties could be the main 
“limiting steps” towards the genome-wide design.  
 
2.6 Materials and methods 
 
Echo PCR 
The GoTaq Green Master Mix (Promega, Madison, WI) was used in the PCR. All PCRs were set up 
using the following cycling conditions: preheat the PCR machine and then put in the PCR plate, 2 
min at 95 °C,32 cycles of 10 s at 95 °C, 30 s at 50 °C and 2 min at 72 °C, followed by 7 min at 72 °C, 
and hold at 4° C. GoTaq Green Master Mix (35 µL) and double-distilled water (ddH2O; 30 µL) were 
added separately to source plate 1, which was an Echo 384-well polypropylene plate (Labcyte). 
YCp2214 and YCp2215 (10 µL each) and template DNA (10 µL) were added separately to source 
plate 2, which was an Echo 384-well low dead-volume plate (Labcyte). The destination plate used in 
this study was MicroAmp EnduraPlate (Life Technologies, Carlsbad, CA). 
 
Echo Gibson assembly 
PCR products were gel purified using the QIAquick gel extraction kit (Qiagen, Valencia, CA). The 
standard 15 µL Gibson assembly master mix was prepared as described in the original Gibson 
assembly paper5. 9 Gibson master mix (40 µL) was added to source plate 1, which is an Echo 384 
polypropylene plate (Labcyte). Each DNA fragment (10 µL) was added to source plate 2, which is 
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an Echo 384 low-dead-volume plate (Labcyte). One-pot Gibson assembly was incubated at 50 °C for 
60 min in a preheated PCR thermal cycler. 
 
Echo Golden Gate assembly 
The Golden Gate master mix contained 35 µL T4 ligase (2000 U/µl, New England Biolabs, NEB), 
35 µL BsaI-HF (NEB), 52.5 µL 10× T4 buffer (NEB), and 25 µL 200× BSA (NEB). Golden Gate 
assembly reactions were set up using the following cycling conditions: 15 cycles of 5 min at 37 °C 
and 10 min at 16 °C, 5 min at 50 °C, 10 min at 80 °C, and hold at 4 °C. Golden Gate master mix (30 
µL) was added to source plate 1, which is an Echo 384 polypropylene plate (Labcyte). pMBP1 PCR 
product (10 µL) and HcKan_P vector (10 µL) were added to source plate 2, which is an Echo 384 
low-dead-volume plate (Labcyte). 
 
Bacterial transformation for Echo assembly reactions 
As the assembly reactions set up by Echo were at the nanoliter scale, it is difficult to take out the 
assembled DNA using pipets and transform them into bacterial competent cells. Instead, bacterial 
competent cells were added to each well containing an assembled product. Competent Escherichia 
coli (20 µL; MAX Efficiency DH5α, Life Technologies) was added to each well of the reaction plate. 
The PCR plate was incubated on ice for 20 min and then placed in a heat block at 42 °C for 45 s. The 
plate was placed back on ice to incubate for additional 5 min, before adding 200 µL of room temperate 
super Optimal Catabolite repression (SOC) medium to each well. The plate was incubated at 37 °C 
with shaking at 200 rpm for 1 h. A multichannel pipet was used to slowly drip 40 µL of each 
transformation mixture onto an omnitray containing selective solid agar medium (LB—Kan). 
Alternatively, 100 µL of transformation mixture was plated on individual petri dishes with selective 
solid agar medium (Golden Gate assembly, LB—Kan; Gibson assembly, LB—Amp). Plates were 
incubated overnight at 37 °C until single colonies appeared. 
 
qPCRTag assay 
For qPCRTag reaction setup, 500nL of mastermix, 5nL of gDNA and 10nL of PCRTag primers were 
dispensed into a 1536 multiwell plate using Echo550. Then the plate was sealed and centrifuged. The 





Gel electrophoresis was performed to analyze the PCR products (120 V, 30 min; 1% w/v agarose in 
Tris-acetate-EDTA (TAE) buffer with 1× SYBR Safe DNA stain). Each PCR product was first 
diluted with ddH2O to a final volume of 5 µL whenever the PCR volume was smaller than 5 µL. 
 
Sanger Sequencing 
A BigDye Terminator v3.1 Cycle Sequencing Kit (Life Technologies) was used to verify the DNA 
assembly clones according to the manufacturer’s instructions, and the Sanger sequencing reactions 
were carried out by Edinburgh Genomics. 
 
SynII and SynVII Segmentation  
Once SynII and SynVII design were completed, segmentation of synthetic chromosome sequence into 
megachunks (~30 kb) and chunks (~10 kb) was performed using BioStudio70. By applying an in-
house developed program called SegMan, each chunk was segmented into minichunks (~3 kb). 
Minichunks were designed to be assembled into chunks by Gibson assembly5, and therefore 40 bp 
overlaps between each adjacent minichunks were added by SegMan. Terminal restriction 
endonuclease sites were also added on both ends of each minichunk to allow excision from the 
plasmid to ensure only 5¢ sticky or blunt ends could be generated by digestion. The 40 bp overlap 
regions were chosen based on the following criteria: minimal free energy > –3 kcal/mol, and melting 
temperature (Tm) of 68±4 °C. Higher free energy of overlap sequence leads to reduced probability 
of self-folding of single-stranded DNA and results in higher efficiency for overlap-based in vitro 
assembly methods. Here the RNAfold program of the ViennaRNA Package 2.092 was used to 
calculate the minimal free energy of the DNA sequence. A simplified formula derived from Rychlik, 
W. et al.93 was applied to estimate the melting temperature: Tm = 945*ΔH/(ΔS + R*log(0.0001)) – 
273.15, in which ΔH is enthalpy (kJ/mol), ΔS is entropy, R is the molar gas constant (1.9872 cal/mol-
K). In addition, to reduce synthesis cost, LEU2 and URA3 markers were designed separately as 
independent cassettes and used repeatedly in minichunk assembly. 
 
Minichunk Assembly 
Synthesis of ~3 kb minichunks was outsourced to Invitrogen, Genscript, BGI Tech and Life Tech. 
pSBGAA or pSBGAK (sequence information can be found at www.syntheticyeast.org) was chosen as 
the accepting vector for chunks. Minichunks were excised from the plasmids using the terminal 
restriction sites. BamHI was used to linearize the chunk-accepting vectors pSBGAA (AmpR) and 
pSBGAK (KanR). The chunks were assembled using a modified Gibson assembly strategy5. In brief, 
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1 µL of Taq ligase (New England Biolabs) was added in the final volume of 20 µL for each reaction. 
The molar ratio of accepting vector to minichunk DNA was 1:5. After thorough mixing, a one-hour 
incubation at 50°C was performed. Then 10 µL of the reaction mixture was transformed into 50 µl 
E.coli DH5α competent cells (TAKARA). For assembly verification, single colonies were picked 
and subjected to overnight culture at 37°C. After miniprep, restriction digestion of the terminal 
restriction sites was performed to check the assembly outcomes. 
 
Replacement of WT Yeast Chromosome with Synthetic Chunks 
BY4741 (MATa his3Δ1 leu2Δ0 LYS2 met15Δ0 ura3Δ0) containing the KanMX marker (strain ID: 
YS000-L) and BY4742 (MATα) containing the URA3 marker (strain ID: YS000-R) were used as the 
initial strains for synthetic megachunk replacement from the left arm and right arm, respectively. The 
URA3 and LEU2 selectable markers were used iteratively for replacing the native sequences of 
chromosome II/VII with synthetic chunks. The chunks constituting each megachunk were co-
transformed using the LiOAc transformation protocol17 with 300 ng of each chunk DNA and 200 ng 
of each junction DNA added. The transformation products were re-suspended in 100 µL 5 mM CaCl2 
and plated on an appropriate selectable media (SC–Ura or SC–Leu) with serial dilutions where 
appropriate. After several successive rounds (from both left and right arms) of replacements, two 
semi-synthetic chromosomes were successfully constructed. The selectable marker URA3 in one of 
the semi-synthetic chromosome was removed through yeast transformation with the corresponding 
markerless synthetic fragment and screened with 5-FOA94.  
 
Integration of parallel constructed semi-synthetic chromosomes 
An I-SceI-mediated method was developed to combine the two semi-synthetic chromosomes, synIIA-
R and synIIR-Y. For synIIA-R, a fragment containing the I-SceI recognition sequence and URA3 (I-
SceI-URA3) was designed to have a 40 bp overlapping sequence both upstream and downstream of 
the LEU2 marker on one of the semi-synthetic chromosome. A previously described method95 was 
used to integrate the I-SceI-URA3 cassette into one of the semi-synthetic chromosomes. In addition, 
a LEU2 marker was inserted into the other semi-synthetic chromosome upstream of the centromeric 
region. Mating of the two semi-synthetic chromosomes was performed by overnight co-culturing in 
3mL YPD medium at 30°C. The I-SceI expression vector pRS413-pGAL-I-SceI was transformed into 
the diploid cells followed by plating on SC–His plate. Single colonies were picked and subjected to 
overnight culture in 3 mL SC–His/glucose medium. The overnight culture was then added to 20 mL 
SC–His/raffinose (2% raffinose and 0.1% glucose) to reach an initial OD600 of 0.1 and incubated 
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until OD600 reached 0.4 (~4-hour). Cells were harvested by centrifugation at 6,200 rcf for 5 min and 
re-suspended in 20 mL SC–His/galactose (2% galactose). After a 2-hour I-SceI induction in 
galactose-containing media, 20 µL cells were inoculated into 3 mL YPD medium, followed by 
overnight culture at 30°C. Overnight culture (1 mL) was harvested by centrifugation at 13,800 rcf 
for 1 min. The pellets were re-suspended in 200 µL ddH2O, patched on a SPOR plate and incubated 
at room temperature for 1 day. Then 5-7 days incubation at 30°C was performed until a significant 
number of tetrads was observed. 
Cells were re-suspended in 25 µL Zymolyase-20T (25 mg/mL in 1 M sorbitol), then incubated at 
37°C, with shaking at 800 rpm for 60 min. Then 500 µL ddH2O was added and mixed thoroughly, 
followed by plating on 5-FOA plates and incubating at 30°C for 3 days. Then replica plating on SC–
Leu and YPD plates was performed, followed by 24 hours incubation at 30°C. FOAR Leu– colonies 
were selected from YPD plates, inoculated into 3 mL YPD medium, and cultured overnight. To verify 
the integration of semi-synthetic chromosomes, one pair of synthetic PCRTag and wild-type PCR 
tag were chosen from each megachunk (in total 25 pairs with one from each Megachunk) to perform 
PCRTag analysis. Then sequencing was performed for further verification. 
 
PCRTags Analysis Reaction setting 
PCRTag amplification was performed using rTaq Polymerase (TAKARA). Forward and reverse 
PCRTag primer pairs (400 nM each, detailed information of PCRTag primers can be found at 
www.syntheticyeast.org), 1 µL 20Mm NaOH treated cell culture and 2.25 µL ddH2O were added to 
a final reaction volume of 12.5 µL. The PCR thermal-cycler program setting was used as follows: 
94°C/5 min, 30 cycles of (94°C/30 sec, 55°C/30 sec, 72°C/30 sec), and a final extension of 72°C/5 
min. Detection of PCRTags was carried out by gel electrophoresis. PCR product (3 µL) was loaded 
onto a 2% agarose gel, and electrophoresis was performed at 180V for 20 min. 
 
Yeast Genomic DNA Preparation for DNA Sequencing 
Yeast cells were grown in 5 mL YPD medium using a 14 mL round bottom tube for 2 days till 
saturation. Pellets were collected by centrifugation at 13,800 rcf for 1 min. Breaking buffer (400 µL) 
was added to re-suspend the pellet. Glass beads (0.2 g, 0.5 mm of diameter) and 400 µL PCI 
(Phenol:Chloroform:Isoamyl alcohol=25:24:1) were added, the re-suspension was vortexed at 
maximum speed for 3 min, and then centrifuged at 13,800 rcf for 10 min. 400 µL of the aqueous 
layer was transferred to a new 1.5 mL tube. The genomic DNA was precipitated by adding 400 µL 
of isopropyl alcohol and kept at room temperature for 5 min. Then genomic DNA was pelleted by 
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centrifugation at 13,800 rcf for 10 min. The pellet was washed with 500 µL 70% ethanol, followed 
by 5 min drying at 37°C. The genomic DNA was re-suspended in 50 µL TE buffer (10 mM Tris-HCl 
pH8.0, 1mM EDTA) with RNase (25 µg/mL) and incubated at 37°C for 30 min.  
 
Nucleotide Sequence Analysis of SynII with Hiseq2500 sequencing platform 
Library preparation and whole genome sequencing 
Paired-end whole genome sequencing was performed for the SynII and SynVII on the HiSeq2500 
platform. A 500-bp library was prepared according to standard Illumina DNA preparation protocols. 
 
Sequencing quality control and mapping to genome sequence 
Before mapping of reads, quality control of sequencing reads was performed. Reads with adapters or 
shorter than 90 bp were removed. Reads with more than one base having a Phred-score below 10 or 
with more than one unknown base were removed, leaving 673 Mbp cleaned paired-end reads, with 
55.6-fold sequencing depth of the genome. Cleaned reads of each sample were mapped to yeast 
reference sequences (the original sequence of chromosome II/VII being replaced by synthetic 
chromosome II/VII sequence) using BWA 0.5.696 with standard settings. For each alignment result, 
local realignment was performed with GATK 2.7-2 RealignerTargetCreator and IndelRealigner 
tools85 to clean up mapping artifacts caused during reads mapping on the edges of indels. The 
resulting files in BAM format were then prepared for initial SNV/indel calling. 
 
Identification of SNVs and indels 
Both Samtools97 and GATK 2.785 pipelines were used to identify the SNVs and indels using default 
parameters. The variants were filtered by the criteria of QUAL < 50 or PV4 < 0.1,0.1,0.1,0.1 or MQ 
<10 or DP < 10 or DP4 < 0,0,3,3 for Samtools results and QUAL < 50 or FS >3 or BaseQRankSum >3 
or MQRankSum>3 or ReadPosRankSum>3 or MQ <10 or DP < 10 for GATK results. The variants 
identified by either tool were merged with CombineVariants implemented in GATK. The merged 
variants in the synthetic chromosome were checked manually using Tablet98 to exclude false-positive 
results caused by sequencing or mapping errors. Annotation was performed for observed variants, 
with the following types: synonymous type, non-synonymous type, frameshifts, and variant outside 
coding region. 
 
Identification of loxPsym sites 
In SynIII, loxPsym sites can be absent from expected locations17. To check whether all loxPsym sites 
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are present in SynII/SynVII, sequencing reads containing loxPsym sites were extracted from the 
whole read library for identifying the presence of all expected loxPsym sites. For each loxPsym site, 
the read mapped span the loxPsym site of upstream and downstream flanking sequence >10 
nucleotides and the sequenced loxPsym site with bases of >=24 matching or mismatching loxPsym 
sequence was recognized as a loxPsym read and bases of >=15 deleted was counted as a 
“loxPsym_lost” read. The loxPsym site with p-value of < 0.001, which estimated by Poisson mode, 
and supporting read number >=5 was identified as a loss of loxPsym site.  
 
Structural variant detection with the PGM sequencing platform 
Library preparation and whole genome sequencing 
A 400-bp DNA library of a SynII was prepared for single-end whole genome sequencing according 
to the Life Tech standard preparation protocol using the Ion Xpress™ Barcode Adapter 1-96 Kit 
(Cat.no.4474517) and sequenced on the Ion PGM™ platform. Quality control of sequencing reads 
was performed. Reads shorter than 30bp or duplicated were removed. Reads with more than 1% of 
bases having a Phred-based quality score <10 or with unknown bases were trimmed first to meet the 
filtering criteria and removed if the first trimming step failed, leaving 488 Mbp cleaned reads, with 
32.6-fold sequencing depth of the genome and 248 bp average length. Cleaned reads of each sample 
were mapped to synthetic yeast genome sequences using bowtie2-2.0.084 with standard settings. 
 
Structural variant reconstruction 
To identify whether structural variations exist in SynII, reads that did not map to the reference genome 
were split to pairwise ends (split reads, at least 30 bp) by scanning over all intermediate positions at 
least 30bp from the ends of the read. Then these pairwise ends were then aligned to the reference 
using Bowtie284 by single-end mapping with parameter –k 100. The pairwise ends that matched 
parental sequence were analyzed for breakpoints to provide direct evidence for structural variants. 
One read was assigned as the most probable mapping type based on five priorities: no recombination 
events (top priority), intra-chromosome recombination, inter-chromosome recombination within 
wild-type chromosomes and external chromosome recombination between synthetic and wild-type 
chromosomes, and single end mapping. For each identified breakpoint, a 5 bp error range was 
allowed. These reads at a breakpoint site with at least 3 supporting reads were locally assembled 
using PolyPhred99, and then the assembly results were annotated by Blastn against the reference 
containing the selection marker and acceptor vector and wild-type chromosome II sequence to 
identify the potential extrinsic sequence. Combining the split-read mapping, sequencing depth and 
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local assembly contigs, the structural variations were reconstructed. 
 
SynII Structural Variant Correction 
An I-SceI mediated transformation strategy was designed to correct the two structural variations 
observed in Megachunks L and T of SynII. For the duplication in Megachunk L, a donor fragment 
containing the URA3 sequence and an I-SceI site (TAGGGATAACAGGGTAAT) was designed to 
carry 40 bp overlapping regions at the end of the original chunk L4 and the beginning of duplicated 
chunk L2. The donor fragment was produced by PCR using primers including the I-SceI site and 
overlap sequence. I-SceI expression vector pRS413-pGAL-I-SceI and the donor fragment were co-
transformed into the synII strain. After I-SceI induction on galactose media, cells were plated directly 
on 5-FOA plates directly and incubated at 30°C for 3 days. Then FOAR colonies were selected and 
cultured overnight in YPD medium at 30°C. Confirmation of repair was performed by PCR using a 
pair of primers designed to amplify across the L4-L2 breakpoint (primer sequence information can 
be found at www.syntheticyeast.org).  
For the complex variation in Megachunk T, a donor sequence was designed to contain a URA3 
cassette and the I-SceI site, with the left end overlapping with the right end of chunk T4 by 500 bp, 
and the right end overlapping with the left end of chunk T5 by 500 bp (Fig. 1B). Both 500 bp 
overlapping sequences and the I-SceI-URA3 cassette were produced by PCR with 40 bp overlaps 
with each other and assembled together through the Gibson assembly method5to form the donor 
fragment. An additional 100 bp of chunk T4 was added between the I-SceI-URA3 cassette and 500 
bp overlapping sequence of T5 to facilitate the homologous recombination. The donor fragment and 
I-SceI expression vector pRS413-pGal-I-SceI were then co-transformed into the SynII in which the 
structural variation in Megachunk L had been repaired. I-SceI induction was performed on galactose-
containing media and colonies were screened on 5-FOA-containing plates. PCR verification was then 
performed with 8 pairs of verification primers designed across each breakpoint observed in this 
structural variation. The SynII was sequence-verified again using the PGM sequencing platform, with 
library preparation and sequencing method as described in “structural variant detection with the PGM 
sequencing platform”. 
 
Mating Type Switch of Yeast 
pJD138 (pGAL-HO) was transferred into the SynII strain using the LiOAc transformation protocol17, 
followed by overnight culture in 5ml SC–Ura/galactose (2% galactose) liquid at 30°C. The mating 




Mating and Sporulation 
Mating of a SynII strain and a second SynII strain that had its mating type switched to alpha (strain 
ID: YS032) were recovered on YPD plates. Colonies were picked and patched in the same section 
(mating section) on a new YPD plate with an inoculating loop, followed by overnight culture at 30oC. 
Then diploid colonies were patched on SPOR plates [10 g potassium acetate (Sigma), 1.25 g yeast 
extract (Oxoid), 1 g glucose (Sangon Biotech), 20 g agar (Sangon Biotech), ddH2O up to 1 L] and 
left at room temperature for one day, followed by 8 days incubation at 30°C. Then cells were picked 
from SPOR plates and re-suspended in 25 µL zymolyase solution (MP Biomedicals, 1 mg/ml 
Zymolyase in 1M sorbitol), followed by 25 min incubation at 37°C. Cells were checked under the 
microscope to determine zymolyase efficiency. After tetrads were appropriately digested, 500 µL 
ddH2O was added and the suspension mixed vigorously by vortexing to break up the tetrads. Then a 
series of 10-fold dilutions were made before plating on YPD plates. The plates were incubated at 
30°C for 2-3 days. Single colonies were picked and streaked on fresh plates, followed by overnight 
incubation. Mating type of random spores was confirmed by crossing with MATa and MATα tester 
strains and confirmed by microscopy. Spore-derived colonies were selected for PCR verification. 
The nine pairs of primers used for identifying breakpoints in SynII were used here to verify the correct 
SynII sequence (primer sequence information can be found at www.syntheticyeast.org). Pulsed-field 
gel electrophoresis (PFGE) was performed for karyotype analysis. Finally, candidates were further 
verified using the PGM sequencing platform, with library preparation and sequencing method as 
described in “structural variant detection with the PGM sequencing platform” above. 
 
Pulsed-field Gel Electrophoresis 
Samples were prepared for pulsed-field gel electrophoresis as previously described by Herschler J, 
et al100. Identification of chromosomes was inferred from the karyotype of WT controls (BY4741, 
BY4742) on the same gel. Samples were analyzed on a 1.0% agarose gel in 1×TAE (pH 8.0) for 22 
hrs at 14°C on a CHEF apparatus. The voltage was set to 5 V/cm, at an angle of 120°. Switch time 
was set to 60 – 90 sec ramped over 22 hrs. 
 
BigDye Reaction setting 
BigDye sequencing PCR reaction includes 0.32ul sequencing primer(10uM), 2ul DNA (80-120ng), 
2ul of 5X Sequencing buffer, 2ul 1:4 diluted Big Dye and 3.68ul ddH2O. Reaction setting is as 
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follows:32 cycles of (95°C/30sec, 50°C/20sec, 60°C/4min), hold at 4°C.  
 
TOPO Cloning 
Reaction of TOPO Cloning includes 1ul TOPO® vector, 0.5-4ul PCR product, 1ul salt solution and 
ddH2O to a final volume of 6ul. Mix the reaction mixture gently and incubate for 5-30mins at RT.  
 
pJET Cloning 
For cloning of blunt-end PCR product, ligation reaction includes 1ul pJET1.2/blunt cloning vector 
(50ng/ul), 1ul purified PCR product, 10ul 2X reaction buffer, 1ul T4 ligase and ddH2O to a final 
volume of 20ul. Mix the reaction mixture gently and incubate for 5-30mins at RT.  
 
T4 ligation 
T4 ligation reaction includes 2ul DNA, 0.5ul T4 ligase, 1ul T4 ligation buffer and ddH2O to a final 
volume of 10ul. Mix the reaction mixture gently and incubate overnight at 16°C.  
 
Bacterial Transformation 
For standard bacterial transformation, a maximum 10ul of transformation DNA is added into 100ul 
Dh5α competent cells, followed by 20 mins incubation on ice; after heatshock at 42°C for 45 seconds 
the cells were stored on ice for additional 10 mins; then 750ul of S.O.C medium was added and the 
cells were recovered in 37°C for 1 hour; finally 200ul of transformation product was plated on 
selection plates. 
For bacterial transformation with MAX Efficiency® Stbl2™ competent cell, 5uL of DNA was added 
to 100ul competent cells followed by incubation on ice for 30 mins; heat shock for 25 sec; further 
incubation on ice for 2 mins; addition of 900ul S.O.C medium; shaking at 200rpm, 30°C for 90 mins; 
spreading 200ul on selection plates; and incubation overnight at 30°C. 
 
Plasmid Isolation from Yeast 
Cells were harvested from 3 ml overnight culture in YPD and resuspended in 250 µl of buffer P1 
(QIAprep miniprep kit). After addition of 100 µl of glass beads, cell walls were broken by vortexing 
for 5 minutes. Following this treatment, plasmids were isolated using the standard alkaline lysis and 
a Qiagen miniprep spin column to isolate the DNA. Aliquots of the shuttle plasmid were used to 





Part 2: Characterization - the fitness assays for SynII and SynVII 
3.1 Introduction 
As described in Chapter Two, thousands of design elements were introduced to the synthetic 
chromosomes following the design principles. The extensive changes made to the chromosome 
naturally raise the question whether there are any phenotypic effects caused by these changes. Here 
in this chapter, in-depth characterizations of both SynII and SynVII were described. Both synthetic 
chromosomes showed varying levels of defects, therefore, debugging methods were also developed 
to quickly identify the defect origins.  
 
3.2 SynII 
During the construction of SynII, a significant fitness defect was observed after Megachunk E 
integration (Figure 3.1, Figure 3.4). Further investigation revealed that the defect was introduced by 
the insertion of the selective marker URA3 (for integration selection) adjacent to the NCL1 gene, 
which encodes a tRNA:m5C-methyltransferase. Loss of function of NCL1 gene was previously 
reported to be involved in slow growth and temperature sensitivity101,102, which could explain the 
observed phenotypic defect. This auxotrophic marker interference phenotype was corrected in the 
next step of SwAP-IN, in which the URA3 marker was replaced by an intact NCL1 gene. Similar 
instances of such reversible fitness defects were also found after integration of Megachunk B, U, and 
W (Figure 3.1).  
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Figure 3.1 Phenotypic assay of all intermediates and the final SynII strain under different 
conditions 
Phenotypic assays under 22 different conditions were performed for all intermediate strains to monitor 
the fitness defect(s). 10-fold serial dilutions of overnight cultures were used for plating. A major phenotype 
defect was observed in the SynIIA-E intermediate strain when culturing under high temperature and in 
the presence of Benomyl and Hydroxyurea (Red highlighted). Another major defect on the YPEG plate 
was also revealed in SynIIR-S, SynIIR-U and SynIIR-W intermediate strains (Orange highlighted).  
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3.1.1 Phenotypic and morphological assays of SynII 
Growth curves, phenotype and morphology under various culture and stress conditions were 
evaluated to check the fitness of SynII strain compared to the wild-type counterparts (BY4741 and 




Figure 3.2 Growth curves of SynII strain under different conditions 
SynII cells were cultured in 22 different conditions and OD600 were measured at indicated time to check 
for growth defects (BY4741 and BY4742 strain as reference). Except for a minor growth defect in media 




Figure 3.3 Phenotypic profiling of SynII on different media 
10-fold serial dilutions of overnight cultures of synII and wild-type (BY4741 and BY4742) strains were 
used for plating. From left to right: YPD at 25°C, 30°C, and 37°C; SC at 25°C, 30°C, and 37°C; low pH 
YPD (pH 4.0) and high pH YPD (pH 9.0); YPEG; SC+6-Azauracil; YPD+Benomyl; YPD+Camptothecin; 
YPD+Hydroxyurea; YPD+Cycloheximide (10 μg/ml, 2 hrs pretreatment); YPD+H2O2 (1 mM, 2 hrs 
pretreatment); YPD+Sorbitol; YPD+MMS, (YPD, yeast extract peptone dextrose; YPEG, yeast extract 
peptone glycerol ethanol; MMS, methyl methane sulfone; SC, synthetic complete). 
 
 
Fitness defect rescue of SynII by complementation assay 
A defect at high temperature (37°C) in medium with glycerol as the carbon source was observed in 
SynII cells: colony size is much smaller than wild-type. By crossing SynII with wild type strain 
(BY4742), it was confirmed that the slow-growth phenotype is recessive (Figure 3.4A). To ascertain 
the origin of this defect, the phenotype of each intermediate strain under this particular growth 
condition was examined. The results show that the defect originated from Megachunk X (Figure 
3.4B). After checking all genes carrying design features in Megachunk X, one essential gene 
YBR265W, which encodes 3-ketosphinganine reductase (Tsc10p) that catalyzes the second step in the 
pathway for sphingolipid synthesis in S. cerevisiae103, was found modified carrying a synthetic 
PCRTag. As sphingolipids are reportedly involved in the regulation of the yeast high-osmolarity 
glycerol (HOG) response pathway104, we reasoned that the defect might be caused by the 
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modification in YBR265W. Using complementation assay by replacing the synthetic PCRTag in 
YGR265W by its corresponding wild-type sequence, we proved that the defect is caused by PCRTag 
recoding in YBR265W (Figure 3.5). This highlights the effectiveness of the genome debugging 
mechanism provided by the modular chromosome construction strategy in the Sc2.0 project.  
 
 
Figure 3.4 SynII defect at 37°C on YPG media 
A. SynII was mated to BY4742 and the resulting diploid cells were spotted on YPG media and incubated 
for 4 days at 37°C for checking whether the mutation responsible for the defect was recessive. B. Spotting 
on YPG plate with intermediate strains SynIIR-W, SynIIR-X and SynIIR-Y, with BY4741 as control. The 





Figure 3.5 SynII defect at 37°C on YPG media is rescued by complementing with wild-type 
YBR265W gene  
A. PCRTag recoding of YBR265W gene. YBR265W was modified in SynII to contain recoded one 
PCRTag. B.The PCRTag was recoded by replacing the modified YBR265W gene with the wild-type gene. 
SynII::YBR265W-URA3 strain spotting on YPG medium was performed, with BY4741 and SynII as 
control. 
 
As more and more individual synthetic yeast chromosomes are near complete, combining them into 
a single haploid cell will be the next step. To this end, we successfully merged SynII and SynIII using 
“endoreduplication intercross” method established previously20. The resulting SynII/III cell grows 
just like WT cells (Figure 3.6), indicating that SynII can be successfully incorporated into another 




Figure 3.6 Phenotypic assay of two SynII/III isolates under different conditions 
10-fold serial dilutions of overnight cultures of SynII/III isolates and wild-type strain (BY4741) were used 
for plating. From left to right: YPD at 30°C, and 37°C; YP + 4% Glycerol at 30°C; YP + 4% Ethanol at 
30°C; SC + Camptothecin (5 μg/mL) at 30°C; YP + 10% Sorbitol at 30°C; YPD+ Hydroxyurea (0.17 M) 
at 30°C; high pH YPD (pH 9.0) and YP + 2% Maltose at 30°C (SC, synthetic complete).  
 
3.1.2 Segregation and replication of SynII 
Once SynII was constructed and phenotypically profiled, a logical next question is to ask how this 
synthetic chromosome replicates and segregates. Therefore, to further investigate whether the 
modifications introduced in SynII compared to WT chromosome II might have introduced subtle 
chromosome defects not detected in large-scale phenotypic assays, we examined and compared DNA 
replication and segregation processes of SynII and WT (BY4741) strains by tagging SynII with an 
array of tet operators and using the previously described TetR-GFP method105. The pRS306tetO14 
plasmid (AMp327) carries 224 copies of tetO sequence on the pRS306 backbone. p128tetR-GFP 
(AMp326) is another vector in which GFP is fused with tet-R on the pRS305 backbone. A 950kb 
region to the 3’ of CEN2 was cloned into pRS306tetO14 and integrated into SynII and BY4741 strains 
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both expressing tetR-GFP, resulting in the generation of a GFP label 15 kb to the right of CEN2. 
Before measurement, alpha factor was first added in the medium to synchronize the CEN2-GFP 
strains in G1. Next, alpha factor was removed by filtration and washing with fresh medium to release 
SynII and wild-type cells from the G1 block into the cell cycle. Sample was collected every 15 mins 
for the next three hours and fixed for later analysis. The separation of sister chromatids at CEN2 was 
scored by counting the percentage of cells in which two GFP dots were visible (Figure 3.7A). We 
found that SynII and BY4741 strains were comparable. The progression of cells from metaphase to 
anaphase was identified by changes in spindle morphology (Figure 3.7A). The overall ratio of 
metaphase to anaphase spindles further confirmed normal cell cycle progression in the SynII strain 
(Figure 3.7B).  
 
 
Figure 3.7 Cell cycle comparisons between SynII and BY4741.  
A. Representative images showing cell morphology at different stages during the cell cycle after 
release from G1 block. DNA staining is shown in blue; CEN2-GFP in G1, S, G2 and M phase are shown 
in green. Spindle morphology in metaphase and anaphase was visualized by immunofluorescence 
(White arrow pointed). The scale bar represents 5 μm. B. Graphs showing the percentage of SynII cells 
with separated CEN2-GFP dots, metaphase spindles and anaphase spindles during the cell cycle. For 
each time point at least 200 cells were counted. The inset numbers indicate the overall ratio of metaphase 
to anaphase cells throughout the time course for SynII and BY4741 strains. 
 
Early activating replication origins are frequently found adjacent to tRNAs and transposable elements 
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containing LTRs106. In SynII, two early origins are no longer linked with tRNAs and LTRs, as they 
were removed by design. Therefore, SynII offers an opportunity to test the functional requirement of 
linkages between these two early replication origins and their corresponding tRNAs and LTRs. The 
replication dynamics analysis for SynII done by Conrad A. Nieduszynski’s group demonstrated that 
the synthetic chromosome showed identical replication dynamics to the wild-type chromosome II 
(Figure 3.8). This finding is consistent with the linkage between early activating origins, tRNAs and 
LTRs not being a functional requirement for early origin activation.  
 
 
Figure 3.8 Replication profiles of SynII (red) and BY4741 (black) 
Replication time is presented as relative copy number by deep sequencing. 
 
Our results show that modifications in SynII show no gross negative effect on key cell cycle 
transitions; including chromosome replication (S phase) and segregation of sister chromatids 
(anaphase). In additional, Hi-C analysis of SynII performed by Romain Koszul’s group also revealed 
no substantial changes between the synthetic and native chromatin, suggesting that the designed 
sequence has little to no negative effect on the average global folding of the chromosome87. 
 
3.1.3 Trans-Omics analysis of SynII  
A systems biology approach (“Trans-Omics” analysis) was used here to evaluate the impact of SynII 
on the genomics, transcriptomics, proteomics and metabolomics of S. cerevisiae. 
 
Genomic stability test of SynII 
The insertion of 267 loxPsym sites in SynII could affect genomic stability. Therefore, we evaluated 
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genome integrity and the frequency of chromosome segment loss in the absence of Cre expression. 
In total, 27 independent single colonies of SynII strain were selected after successive subculture of 
~130 generations for PCRTag analysis. PCRTag analysis showed that no deletions were observed in 
all 27 independent isolates derived from over 130 mitotic generations from 9 independent lineages 
(Figure 3.9A,B). The overall loss rate was estimated lower than 5.9 x 10-6. And in addition, 9 of the 
27 single colonies were sequenced by the PGM sequencing platform. The deep sequencing analysis 
of 9 derived single strains showed that no mutation or genome rearrangement was observed, 
indicating that genome stability was faithfully maintained even after 100 generations of nonselective 
growth (Figure 3.9C). 
 
Omics profiling of SynII 
Transcriptome profiling identified only 18 out of 6,561 genes to have differential mRNA expression 
in comparison to the wild-type, with 7 up-regulated and 11 down-regulated (FDR < 0.01 and p-value 
< 7.62E-06, Figure 3.10A, Table 3.1). For the 18 identified differentially expressed genes, 6 are on 
SynII. However, KEGG and GO analysis did not find further evidence of these genes significantly 




Figure 3.9 Genome stability of the SynII strain 
A. In total, 27 independent single colonies of SynII strain were selected after ~130 generations for 
PCRTag analysis, and in addition, 9 of the 27 single colonies were sequenced by the PGM sequencing 
platform. B. In total, 48 PCRTags (2 PCRTags located in nonessential genes from each megachunk) 
were chosen for PCRTag analysis to check the loss of different segments in the absence of SCRaMbLE. 
C. PCRTag analysis and PGM sequencing result show that without SCRaMbLE no losses were observed. 





Table 3.1 List of genes with differential expression levels in SynII compared to BY4741 
Genes on SynII are shown in bold. *Gene adjacent to telomere. 
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In the proteomics analysis, mass spectrometry was performed on SynII strain, with BY4741 strain as 
control. Mass spectrometry provided abundance data for 3,965 out of 6,682 protein-coding genes, 
and only 6 proteins showed substantial differential abundance in SynII strain compared with wild-
type strain (Figure 3.10B, Table 3.2).  4 of the 6 proteins are expressed from genes on SynII: 
YBR296C protein expression level was doubled than that of wild type, while YBL101C, YBR218C 
and YBR056W protein expression level were down-regulated. Finally, metabolomics profiling was 
performed by metabolic LC-MS analysis. In total 4,941 and 6,417 mass spectra peaks with CV <30% 
were identified in positive and negative mode respectively, mapping to 1,032 unique metabolites, 
Fewer than 0.78% of the metabolites were differentially represented (Figure 3.10C,D). Potential 
differentially regulated metabolites included sphingolipids, glycerophospholipids, steroids and 
steroid derivatives (Table 3.3). Interestingly these are all molecules associated with the membranes. 
 
 
Figure 3.10 SynII strain Omics profile (BY4741 as reference) 
A-D Identified dysregulated genetic features at (A) transcriptome level, (B) proteome level and (C and D) 
metabolome level (Metabolic and lipid profiling in LC-MS positive mode respectively) of SynII cells, 
compared to BY4741 cells. The total number of molecules with differential abundance expressed (p-
value < 0.001) in transcriptome, proteome and metabolome are also presented as well. Up-regulated 
and down-regulated molecules are labeled in red and green respectively. 
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Table 3.2 List of genes identified from proteomics data with differential protein expression 
levels in SynII compared to BY4741 




Table 3.3 List of metabolites with different levels in SynII compared to BY4741 from 
metabolomics data and Lipidomics data 
 
Moreover, we also observed cellular defects that potentially arise from the Sc2.0 overall design 
principles. Compared to the WT strain, a subtle but potentially biologically significant up-regulation 
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of genes with the GO terms “ribosome” and “cytoplasmic translation” was observed in the synII 
strain at both the transcriptome and proteome level (Figure 3.11, Figure 3.12A, B, C, D & E). Similar 
up-regulation was also observed in the synV and synX transcriptomes (Figure 3.13). It is known that 
deletion of multi-copy tRNA genes can lead to increased output of the translation machinery107, thus 
we reasoned that the up-regulation of translational activity might be caused by the deletion of the 13 
tRNA genes in SynII, which are all from multi-copy tRNA gene families. To test this we introduced 
an array containing all tRNA gene from chromosome II into SynII and found that the introduction of 
tRNA array to SynII greatly diminished the increase in translational functions (Figure 3.14).  
 
Figure 3.11 GO terms of the enriched pathways and the co-expression profile revealed by 
transcriptome and proteome analyses 
Up-regulated features are labeled in red and down-regulated features are labeled in green circles. 




Figure 3.12 Correlation between the differentially expressed genes with different GO terms 
identified by transcriptomics and proteiomics analyses 
X-axes and Y-axes are log2-based gene expression values of transcript level and protein level 
respectively. Within “Structural constituent of ribosome” (A), “Cytoplasmic translation” (B), “Ribosome” 
(C), “Structural molecule activity” (D) pathways, “Cellular amino acid metabolic process” (E) 
“Transcription from RNA polymerase II promoter” (F), and (G) “mRNA Processing”, genes that are 




Figure 3.13 Enriched yeast KEGG pathways (A) and Go terms (B) with significant up-regulated 
and down-regulated genes of SynII, SynV and SynX strains compared to BY4741 control 
Significance level is indicated by color intensity. (C-H) correlation analyses of differentially expressed 
genes categorized by GO terms between SynII and SynV, or SynII and SynX strains. The scatter plots 
indicate log2-based differential gene expression values of SynII, SynV and SynX strains. Within 
“Ribosome [sce03010]” (C, F), “Cytoplasmic translation [GO:0002181]” (D, G) and “Structural constituent 
of ribosome [GO:0003735]” (E, H), genes that are consistently up-regulated/down-regulated are labeled 




Figure 3.14 RNAseq analysis of SynII with and without tRNA array 
By adding back the tRNA array of SynII, the increase in the translation is greatly reduced. Significance 
level is indicated by color intensities and sizes of the red circles.  
 
In summary, despite some subtle differences, the Trans-Omics analysis provides clear evidence that 
the biological processes within the SynII strain are highly consistent with the wild-type strain. 
Therefore, the yeast genome displays a great degree of plasticity, and can readily cope with the large 
degree of editing encoded into SynII.  
 
3.3 SynVII 
3.2.1 Fitness defect rescue of SynVII by complementation assay 
In contrast to SynII, the construction of SynVII proved to be more challenging. Several defects have 
been identified in SynVII, which are most likely introduced by the design features.  
 
Defect mapping of SynVIIS-Y intermediate strain by SGA 
The semi-synthetic right arm of SynVII, SynVIIR, was fully constructed after 11 runs of step-wise 
replacement with synthetic fragments. After a routine phenotypic check by growth curve analysis, 
SynVIIR was found to have a minor growth defect is that its lag phase is longer than wild-type cells 




Figure 3.15 Growth curve analysis of SynVIIR 
A 30-hours growth curve analysis in YPD medium was performed at 30℃ for SynVIIR, with wild-type 
strain (BY4742) as control. A longer lag phase was found in SynVIIR comparing to BY4742. 
 
In order to pinpoint the defect origin, all 11 intermediate strains were recovered and spotted side-by-
side and incubated at 30℃	 for 4 days. The results revealed that the defect origin was within 
Megachunk S, as the defect starts to show in all intermediate strains after the Megachunk S 
integration (Figure 3.16). In total 23 genes were modified to incorporate different design features in 
Megachunk S (Table 3.4). Neither prior studies nor any supporting evidence was found that linked 
any of these genes to the observed defect. Therefore, the complementation assay that has been 
effective to rescue the fitness defect of SynII is not feasible here due to the fact that in total 49 design 
features, including PCRTag recoding, loxP site insertion and stop codon swap, are potentially 
involved (Table 3.4). 
As the defect was found in the most common yeast culturing condition, indicating the potential 
responsible modification(s) altered genetic interactions which failed to maintain normal cellular 
functions108. This led to a hypothesis that if a single mutant (here refers to the defect causing gene) 
is responsible for the cell fitness defect, then the double mutant of the gene should also show the 




Table 3.4 Design features in SynVII Megachunk S 
 
 
Figure3.16 Growth defect found in SynVIIR intermediate strains 
With BY4742 strain as control, all intermediate SynVIIR strains were spotted on YPD and incubated at 
30°C for 4 days. A growth defect is detected in all strains containing synthetic Megachunk S.  
 
A well-established method termed “synthetic genetic array” (SGA) analysis, in which a query 
mutation is crossed with a pre-designed yeast gene-deletion mutant library to identify of functional 
relationships between genes in a high-throughput manner109,110. Our hypothesis is that the synthetic 
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design features such as PCRTag recoding, loxp site insertion and stop codon swap might lead to the 
functional dysregulation of genes containing synthetic design features. Therefore, the deletion mutant 
library offers a great opportunity to potentially identify the nature of the defect in synthetic 
Megachunk S . In Megachunk S, 20 of the 23 genes in Megachunk S have corresponding gene-
deletions in the SGA library (the remaining 3 are essential genes). By mating these deletion strains 
individually with the defective SynVIIS-Y strain, the resulting diploid strain with one copy gene been 
deleted and another copy gene that cannot maintain proper function might also show the observed 
growth defect, and spontaneously lead us to the defect origin (Figure 3.17). On the other hand, even 
if the defect is rescued after mating, then it means our target(s) can be narrowed down to the 3 
remaining essential genes.  
 
 
Figure 3.17 Illustration of SGA-mediated debugging strategy 
Defect carrying strain is served as the query strain and mated individually with single mutant strain library 
selected with gene of interest. The resulting diploid query strains are cultured on solid media for 
phenotypic assays.  
 
To test the hypothesis, 20 gene-deletion mutants from the ~5000 yeast gene-deletion mutant library 
were picked and recovered. These mutant strains were mated with the SynVIIS-Y strain as well as a 
control SynVIIT-Y strain. The spotting assay revealed that the SynVIIS-Y /YGR160W-deletion diploid 
strain showed exactly the same phenotype comparing to SynVIIS-Y haploid strain (Figure 3.18). 
Therefore, modification of the YGR160W gene, which a loxp site was inserted in its 3’UTR region, 
is most likely the cause for the fitness defect observed.  
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Figure 3.18 SynVIIS-Y and SynVIIT-Y diploid spotting 
SynVIIS-Y and SynVIIT-Y were mated with selected BY4742 derived single gene mutants and spotted 
for phenotype verification, with wild-type haploid and diploid strains, and SynVIIS-Y and SynVIIT-Y 
haploid strains spotted on the side as phenotypic control. The SynVIIS-Y/YGR159C-deletion diploid 
strain and SynVIIS-Y /YGR160W-deletion diploid strain were highlighted in red and blue respectively. “S” 
labeled diploid strains are SynVIIS-Y mating strains with single gene mutant strains, “T” labeled diploid 
strains are SynVIIT-Y mating strains with single gene mutant strains. Number “1 – 8” are YGR154C, 
YGR155W, YGR157W, YGR159C, YGR160W, YGR161C, YGR161W-C and YGR162W single gene 
mutant strains respectively.  
 
Interestingly, the YGR160W gene largely overlaps with the YGR159C coding region. Assuming the 
gene-deletion strategy used is replacing each of the ORFs in the yeast genome with a KanMX4 
cassette (details can be found from the Saccharomyces Genome Deletion Project website: 
http://www-sequence.stanford.edu/group/yeast_deletion_project/deletions3.html), the YGR159C 
double mutant is expected to show the same fitness defect.  However, the YGR159C double mutant 
maintained a normal phenotype (Figure 3.18, blue highlighted). No further details were found 
regarding whether an alternative deletion strategy was used for genes with overlapping ORFs, 
therefore, sequencing of the YGR159C and YGR160W gene-deletion strains was performed. Results 
showed that the whole ORF of YGR160W was disrupted as expected. However, the whole ORF of 
YGR159C gene-deletion mutant remained intact, indicating that the general deletion strategy for the 
Saccharomyces Genome Deletion Project is not the same for overlapping ORFs. This explained why 




Both RNAseq analysis (Table 3.5) and rtPCR analysis show that the level of YGR159C mRNA in 
SynVIIS-Y strain is significantly higher than that in wild type strain (blue bar in Figure 3.19B), while 
YGR159C mRNA abundance in synVIIT-Y strain is similar to wild type (yellow bar in Figure 3.19B). 
Upregulated YGR159C gene expression suggests that modifications introduced by design is 
responsible for the phenotypic defect.  
 
 
Table 3.5 RNAseq analysis of YGR159C gene in SynVIIS-Y and SynVIIT-Y strains 
YGR159C gene (gene ID: NSR1) with differential expression levels in SynVIIS-Y and SynVIIT-Y 
compared to BY4741 (p < 0.05). 
 
 
Figure 3.19 rtPCR analysis of YGR159C gene in SynVIIS-Y and SynVIIT-Y strains 
A. Three sets of primers were designed for the rtPCR analysis of YGR159C gene. B. Relative expression 
levels of mRNA in SynVIIS-Y and SynVIIT-Y strains in comparing with native strain BY4741. 
 
Although the role of each modification to the YGR159C gene in contributing to the defect is not 
entirely clear, SGA analysis and sequencing have narrowed down the potential defect targets from 
49 to 4, and facilitate further defect troubleshooting by complementation assays.  
 
Other defect mapping in the final SynVII strain 
Another severe defect was found when a ~10 kb wild-type region in megachunk W was replaced 
with synthetic DNA in the final SynVII strain. Three yeast isolates were obtained that either partially 
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or completely replaced the wild-type region with synthetic megachunk W (Figure 3.20A). However, 
growth curve analysis shows that all three isolates had severe growth defects (Figure 3.20B). 7 genes 
with a total of 23 design features are potentially responsible for this defect (Figure 3.21A). In order 
to find the cause of the defect, complementation assays with each gene was performed. Surprisingly, 
modifications of multiple genes were found to be responsible for this severe defect (Figure 3.21B), 
suggesting the modifications in this region interfere with function of multiple genes. 
 
Figure 3.20 Growth defect of final SynVII strain caused by design features in megachunk W 
A. The sequence map constructed by sequencing data of three SynVII isolates with partial or complete 
synthetic sequence in megachunk W. Green: synthetic region, Orange: wild type region, Blue: involving 
genes in this region. B. Growth curve analysis of the three isolates shows severe defects compared to 
wild-type strains, semi-synthetic SynVII strains or complete SynVII strain with the 10kb wild-type 




Figure 3.21 Design feature summary of defect causing region in megachunk W and 
corresponding complementation assay 
A. Three types of design features were included in the defect causing region: tRNA deletion labeled as 
“X”, PCRTag recoding (grey bars) and loxP site insertion (green bars). Wild type region are in orange. B. 
Complementation assay of each involved genes in the defect causing region. Each involved gene was 
amplified out from wild type strain and cloned into pRS415 vector and transformed into SynVII H7 strains 
containing full synthetic megachunk W for phenotypic assays.  
 
3.4 Conclusion and discussion 
To summarize, extensive Trans-Omics tests were conducted, including phenomics, transcriptomics, 
proteomics, chromosome segregation and replication analyses, which demonstrated that the SynII 
strain, despite significant sequence alterations, maintains a near wild type phenotype. However, our 
analyses reveal that 10% scale up-regulation of many components of the translational machinery (for 
example ribosomal proteins at both the RNA and protein levels) is a typical feature characteristic of 
synthetic chromosome replacement strains, and the main cause for this was shown to be the reduction 
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in the tRNA gene copy number. Our comprehensive phenotypic assays of SynII strains also revealed 
the plasticity of the yeast genome. SynVII seems to be more sensitive to perturbations as much more 
severe growth defects were found related to certain design features introduced.  
For each designer chromosome in Sc2.0 projects, thousands of changes have been introduced. It may 
be premature to suggest that the Sc2.0 design is too conservative, since strains hosting multiple 
synthetic chromosomes may have more profound phenotypic differences from the wild type due to 
the trans-interactions among designer features in different chromosomes. Growth rates determined 
under standard conditions would not be enough to reveal subtle changes. The Trans-Omics approach 
represents a powerful way to capture subtle changes at different levels. Therefore, as shown in this 
chapter, more in-depth analyses were introduced and established, e.g. monitoring cell replication and 
segregation, examining DNA, RNA, protein and metabolic profiles. For defect mapping, the modular 
construction approach implemented in Sc2.0 projects provides an important mechanism to 
systematically discover and repair phenotypic defects during construction and has greatly reduced 
the workload of debugging by narrowing down the target into one 30-50 kb megachunk region. The 
defect generated by PCRTag recoding in YBR165W gene of SynII was identified in such way. 
However, this approach loses its advantage when there are multiple potential defect origins involved, 
such as the severe growth defect found in SynVII, indicating genetic interactions occur when mutant 
alleles of two or more genes collaborate to generate an unusual composite phenotype. In this case, 
SGA-mediated defect mapping method was developed to address the challenge, as it enables 
systematical screening of potential targets in parallel. Interestingly, most defects were found to be 
caused by the PCRTag recoding (SynII, SynV and SynXII). Although the recoding was performed 
synonymously, it may have altered protein expression levels due to altered codon usage. Therefore, 
for future genome redesign it is imperative to take the codon usage bias into account.  
In conclusion, we have demonstrated that the SynII strain segregates, replicates and functions (at the 
Trans-Omics level) in a very similar way to its wild-type counterpart which has naturally evolved 
over millions of years. On-going further investigations have been arranged for SynVII to eliminate 
all potential defects that might interfere with future studies. 
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3.5 Materials and methods 
 
Growth Curve Assay 
The growth curve analysis of BY4741, BY4742, and SynII was carried out using a Bioscreen C 
system (Oy Growth Curves Ab Ltd). Overnight cultures were sub-cultured into 300 µL of the 
different media to a final OD600 of ~0.1 in the 96 well micro-plates. The assay was performed in 3 
replicates for each sample. Medium alone was used as the negative control.  
 
Serial dilution assay on different medium plates 
BY4741, BY4742, all intermediate and final SynII strains were inoculated in YPD medium at 30°C 
overnight. Then 1:10 serial dilutions were performed using these samples and plated onto different 
medium plates, which including: YPD, YPD with MMS (testing for DNA damage repair), YPD with 
benomyl (a microtubule inhibitor), YPD with Camptothecin (a topoisomerase inhibitor), YPD with 
Hydroxyurea (testing for defective DNA replication), YPD with various final concentrations of 
Sorbitol (0.5 M, 1 M, 1.5 M, 2 M) to cause osmotic stress, synthetic complete (SC) medium, SC with 
6-Azauracil (testing for defective transcription elongation), YPEG (respiratory defects) containing 
2% Glycercol and 2% Ethanol (testing for respiratory defects), and YPD adjusted to pH 4.0 and pH 
9.0 with HCl and NaOH (testing for vacuole formation defects). Two specific drugs, Hydrogen 
peroxide (testing for oxidative stress) and Cycloheximide (testing for defective protein synthesis), 
were used to treat the cells for two hours by directly adding them to overnight cultures. Yeast cells 
were collected by centrifugation and resuspended in water before serial dilution and plating. Plates 
were incubated at 25°C /30°C /37°C for 2/3/4 days. 
 
Cell Morphology 
Cells were grown to log phase in YPD at 30°C. DIC Images were collected using a Nikon microscope 
Ti-E (100X) with an Andor Zyla 5.5 camera. 
 
CEN2-GFP Strain Construction and Culture 
To create the CEN2-GFP strain, a 950 bp region to the right of CEN2 was cloned into AMp327105 
and integrated into the SynII strain and BY4741 carrying tetR-GFP, generating a GFP label 15 kb to 
the right of CEN2. Cell cycle synchronization of CEN2-GFP strains was performed by adding alpha 
 125 
factor to YEP medium. Alpha factor was removed by filtration and washing with fresh YEP medium 
to release cells from G1 block into the cell cycle.  
 
Microscopy 
Methods of fixing cells for GFP-labeled chromosome visualization and indirect immunofluorescence 
were previously described by Fernius et al.105. α-tubulin was visualized using a rat anti-α-tubulin 
antibody at a dilution of 1:50 in PBS/BSA and an anti-rat FITC antibody at a dilution of 1:16.67 in 
PBS/BSA. Microscopy was performed on a Zeiss Axioplan 2 microscope and images were captured 
using a Hamamatsu camera operated through Axiovision software. To score GFP dots and spindles 
in mitosis, cells were co-stained with DAPI to visualize DNA morphology. For each sample obtained 
at each 15-min time point, 200 cells were counted in the field to score GFP dots and spindles. EC 
Plan NeoFluar objective lens (x63, Oil, numerical aperture of 1.25) was used. Camera pixel size is 
6.3 pixels/µm. 
 
SynII Replication Timing Profiles Analysis 
Replication timing profiles were generated from asynchronous cultures using fluorescence-activated 
cell sorting technique been established previously111. Asynchronous cells were fixed with 70% 
ethanol, treated with RNaseA and Proteinase K and stained with 10× SYTOX® green nucleic acid 
stain (Invitrogen). At least 30 million cells were sorted from a particular cell cycle stage using a 
MoFlo Sorter (Coulter Beckman). Sorted cells were treated with Zymolase, RNaseA and Proteinase 
K. DNA was purified using phenol-chloroform extraction and ethanol precipitation. Single end 
Illumina HiSeq2500 sequencing yielded a minimum of 29.6 million uniquely mapped reads per 
sample. The ratios between uniquely mapped reads from the non-replicating and the replicating 
samples were calculated for every 1000 bp window. The ratios were normalized to control with a 
baseline of one for differences in the number of reads between the samples. 
 
Genome Stability Analysis 
SynII was streaked on YPD plate and incubated at 30°C for 2 days. Nine single colonies were selected 
for successive subculture in YPD medium for ~130 generations, followed by plating on YPD plates 
overnight. Three single colonies of each initial isolate were selected. Genomic DNA preparation was 
performed for all 27 isolated single colonies. 48 pairs of PCRTags were chosen to perform PCRTag 
assay for all 27 isolated single colonies. Sequencing on the PGM platform was conducted for 9 of 
the 27 isolated single colonies (one from each initial isolate), with library preparation and sequencing 
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method as described in “structural variant detection with PGM sequencing platform” in Materials 
and Methods of Chapter Two. Sequence data was analyzed according to the method described in 
“Nucleotide Sequence Analysis of SynII with Hiseq2500 sequencing platform” in Materials and 
Methods of Chapter Two. 
 
Yeast Total RNA Isolation for RNA Sequencing 
3 biological replicates of both SynII and BY4741 strains were cultured overnight in 3 mL YPD 
medium at 30°C. The cultures were added to 10 mL fresh YPD medium and incubated until the OD600 
reached ~0.8. The cells were harvested by centrifugation at 900 rcf for 5 min. Total RNA was isolated 
using the RiboPure-yeast kit (Ambion) according to the manufacturer’s instructions.  
 
RNA-seq Analysis of SynII 
The 330 bp cDNA libraries were prepared according to the manufacturer’s instructions (Illumina Inc.) 
and were paired-end sequenced using the Illumina Hiseq2500. Raw reads were filtered using the 
following criteria: no N bases, no adaptor sequences, minimum read length 100, bases of low quality 
(<10) was no more than 1% in a read. An average of 7.0 M and 8.6 M clean reads were obtained 
from BY4741 and SynII samples respectively, with 95.7% and 95.2% mapped to the corresponding 
genome reference. Clean reads were mapped to genomes by tophat v2.0.10112, with the parameter –r 
(--mate-inner-dist) of 130. After reads counting, RPKM was calculated for each gene. Differential 
gene expression was analyzed by DEseq v1.20.0113, with the no replicates scenario (parameters were: 
--method blind, --sharingMode fit-only, --fittype, local). For each gene, a raw p-value and adjusted 
p-value using the Benjamini–Hochberg procedure were obtained. Genes were assessed for statistical 
significance by rejecting the null hypothesis if the adjusted p-value (FDR) was <0.01 and if the raw 
p-value fell below the threshold of the 5% Family Wise Error Rate (FWER) after Bonferroni 
correction (threshold=7.62E-06). False positive results were inferred by the following rules and 
removed: dubious genes, transposable genes, genes with low coverage (<60%) for native and 
synthetic strains. 
 
Proteome and Metabolome Analysis of SynII 
3 biological replicates of both BY4741 and SynII strains were cultured overnight in 3 mL YPD 
medium at 30°C and re-inoculated in 10 mL fresh YPD medium for further incubation until the OD600 
reached ~0.8. The cells were collected for both proteome and metabolome analysis. Proteins from 
the yeast cell were extracted with Urea, reduced, alkylated, digested with trypsin and iTRAQ labeled- 
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BY4741 (113, 115, 117, 121) and SynII (114, 116, 118 and 119) (AB SCIEX, Framingham, MA, 
USA). After labeling, the peptides were fractionation with the SCX method and analyzed by an 
Orbitrap Q Exactive mass spectrometer (Thermo Fisher Scientific, San Jose, CA) coupled with an 
online HPLC. Mascot and IQuant114 software was used for protein identification and quantification.  
For the global metabolomics analysis, metabolites were extracted with buffer (50% methanol and 50% 
water), separated with a BEH C18 column. For the lipidomics, metabolites were extracted with buffer 
(75% dichloromethane and 25% methanol), separated with a CSH C18 column. The metabolites were 
detected by a XEVO-G2XS QTOF mass spectrometer (Waters, Manchester, UK) and the raw 
spectrums were processed by Progenesis QI 2.0 software (Nonlinear Dynamics, Newcastle, UK) for 
peak picking, alignment, normalization and identification. Further statistical analysis was performed 
on the resulting normalized peak intensities using in-house developed software metaX. Pathway 
analysis was conducted using the MetaboAnalyst pathway tool115. 
 
Yeast KEGG pathway and GO enrichment 
To identify the differences in biological processes between SynII and BY4741 strains, gene 
enrichment and co-expression enrichment analyses were performed using yeast KEGG pathways and 
yeast Gene Ontology (GO) annotations using transcriptomics, proteomics and metabolomics data 
respectively. Genes and metabolites with differential expression of log2 (fold-change) >0 and down-
regulation of log2 (fold-change) < 0 were considered as up-regulated and down-regulated for 
enrichment analysis. The significance of each KEGG pathway and GO term in genes, metabolites, 
as well as their co-expressions was individually identified using the hyper-geometric test and Chi-
squared test with false discovery rate (FDR) correction and the threshold P-value < 0.001. The KEGG 
category and interaction between genes and metabolites were classified based on the Yeast 
Metabolome Database116 (http://www.ymdb.ca/system/downloads/current/ymdb.json.zip). 
 
Mating type verification by yeast colony PCR 
Three primers were designed that can specifically amplify the corresponding mating type sequence 
(primers YCp3517, YCp3518 and YCp3519), generating a 404bp amplicon for MATα type strain and 
a 544 bp amplicon for MATa type strain. Cell culture is pre-treated with 40nM NaOH at 95°C for 15 
mins. Then the supernatant was used as template for PCR. PCR program setting is as follows: 95°C/3 
min, 32 cycles of (95°C/30sec, 55°C/1min 30sec, 72°C/30sec), and a final extension of 72°C/7 min. 
Visualization of PCR products was carried out by gel electrophoresis. 12 uL of each PCR product 







Part 3: SCRaMbLE - to explore the potential of SynII and SynVII by 
applying SCRaMbLE 
4.1 Introduction 
As one of the key features of Sc2.0 project, the SCRaMbLE system, which is based on a chemically 
inducible Cre recombinase16,117, was incorporated to permit global genome rearrangements. The loxP 
site introduced in synthetic yeast genome is symmetric (hereinafter referred to as loxPsym site), 
thereby the combination of each two loxPsym sites can generate a diverse population of cells with a 
selectable phenotypic diversity. Theoretically, the “build-in” tool SCRaMbLE holds the potential to 
allow accelerated evolution of the synthetic yeast strains. It can be used for basic research to gain 
knowledge about structure and influence of chromosomal architecture for the phenotype as well to 
generate miniaturized yeast strains. On the other hand, it can be used to optimize yeast strains for 
biotechnological applications in a faster, more complex and directed way compared to standard 
random mutagenesis experiments which rely mostly on small deletions and point mutations. In this 
chapter, the workflow of genome sequence reconstruction of SCRaMbLEd SynIXR strains using deep 
sequencing data will be described first followed by the discussion of using SCRaMbLE for fitness 
defect debugging of SynII and aneuploid SynVII.  
 
4.2 Genome sequence reconstruction of SCRaMbLEd strains with deep sequencing 
data 
While initial applications of SCRaMbLE have been promising117, many potential challenges exist. 
First, introducing multiple loxPsym sites may induce genome instability even in the absence of Cre 
recombinase; after Cre induction has been shut off, leaky Cre expression or continuing Cre activity 
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may lead to instability. When Cre is active, recombination between loxPsym sites and off-target sites, 
albeit at extremely low frequency, may occur118. For desired recombination at loxPsym sites, random 
pairing is desirable to obtain maximum diversity. However, the 82 bp minimum distance required 
for loxP recombination119 and emergent recombination hotpots may further reduce diversity of 
SCRaMbLEd products. Detailed characterization of the genomes resulting from SCRaMbLE is 
required to answer these questions, however, the genome rearrangements generated by SCRaMbLE 
may not be amenable to standard genome sequencing and assembly methods. Therefore, it is 
important to develop alternative method(s) that allow accurate analysis of SCRaMbLEd genomes. 
To this end, 63 previously isolated circular-SynIXR SCRaMbLEd strains from Dymond, et al. 16were 
used to establish the genome reconstruction workflow as well as to detect any unexpected ectopic 
recombination event. The 63 SynIXR SCRaMbLEd strains were generated by Cre induction and then 
selected for auxotrophies arising from loss of function of LYS1 or MET28 encoded in the synthetic 
region. 33 lys-, 20 met- and 10 lys- met- strains were isolated. 
 
Together with one wild-type strain BY4741 and two non-SCRaMbLE parental strains, all 63 SynIXR 
SCRaMbLEd strains were sequenced. For each strain, short-insert libraries with average insert size 
of 500 bp were generated without PCR amplification to avoid creating artefacts through crossover 
PCR at loxPsym sites. For ten strains whose rearrangements were too complex to be resolved with 
short inserts (see details in section 4.1.3 “Full sequence reconstruction”), long-insert libraries with 
an average 10 kb insert size were prepared; long-insert library generation was less efficient and 
required a standard PCR amplification step120. Paired-end sequencing for all libraries was performed 
on the Illumina HiSeq 2000 platform. After stringent quality filtering, short-insert sequences with 
37-fold sequence coverage on average were obtained ready for analysis. 
 
4.2.1 Nomenclature of segments and junctions 
SCRaMbLE is designed to generate diversity by combinatorial rearrangement of segments flanked 
by designed recombination sites. The original segments are represented as consecutive integers, 1 
through 43 for SynIXR (Figure 4.1). The loxPsym junctions are denoted by the unique left (“L”) and 
right (“R”) ends connecting the two segments. For example, the loxPsym site at the junction between 
 131 
segments 1 and 2 involves half-sites 1R and 2L. After the SCRaMbLE process, the rearranged 
chromosome is represented using standard gene order conventions as a list of the segments in their 
new order, with junctions connecting adjacent segments, and an additional junction between the final 
and initial segment in the circular-SynIXR chromosome. Deletions and duplications change the 
number of times that a segment appears, and inversions reverse the order of the affected region. 
 
 
Figure 4.1 The circular SynIXR synthetic chromosome 
SynIXR chromosome comprises 43 segments, numbered consecutively as shown, with loxPSym sites 
(orange bars) serving as junctions between adjacent segments. Arrows indicate genes, with colors 
denoting essential genes (red), auxotrophic markers (purple), other non-essential genes (light blue), and 
the chloramphenicol resistance marker (green). The centromere, in segment 2, is shown as a black circle. 
The left and right ends of each segment are denoted as “L” and “R”, respectively. And loxPsym sites are 
denoted by the unique half-sites of the segments they join.  
 
With junction and segment defined, an in-house software pipeline was developed to efficiently 
identify recombination breakpoints and other sequence variation relative to the parental strain (Figure 
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4.2). Reads with loxPsym sequence were analyzed separately for direct evidence of recombinations 
and classified as “parental junctions”, “novel junctions” involving a recombination between pairs of 
designed loxPsym sites, or “off-target junctions” involving the recombination of a designed loxPsym 
site with any off-target sequence. Recombinations not involving loxPsym sites were termed “ectopic 
rearrangements”. Novel junctions and copy number variation were then used to classify underlying 




Figure 4.2 SCRaMbLE reconstruction pipeline 
Paired-end reads were aligned to identify both parental and novel junctions, copy number of each 
segment and ectopic recombination events. By combining the analysis of junction and copy number, 
Eulerian path was applied for the genome reconstruction.  
 
4.2.2 Analysis of off-target and ectopic recombination 
The first question addressed was: Do Cre generated semi-ectopic recombinations between native 
loxPsym sites and cryptic loxP sequences occur in the yeast genome? Such events have been reported 
to occur albeit at an extremely low frequency118. No evidence for such events was detected in the 63 













































































designed loxPsym sites. The average read depth of 21.5 for these novel junctions was not appreciably 
different from the average of 21.2 for the 2384 sequenced parental junctions. In contrast, the 
maximum read depth for any ectopic loxPsym recombination was only 2, suggesting these reads 
represent ligation artefacts rather than real recombination events. 
Next, fully ectopic recombinations not involving loxPsym or loxP relevant sequences was examined. 
The average read depth for non-synthetic nuclear chromosomes was 36.1, greater than the read depth 
for SynIXR and possibly reflects greater recovery of linear vs. circular chromosomes. Previous studies 
using comparative genome hybridization and quantitative PCR also found reduced recovery of 
SynIXR16. The maximum read depth for any putative ectopic recombination was essentially the same 
for the parental strain (maximum read depth 8) and the SCRaMbLEd strains (maximum 10 across all 
64 strains), and far less than the average read depth. Furthermore, 80.8% of the reads supporting 
putative ectopic recombinations involved mitochondrial genome sequence, which, due to 
mitochondrial copy number, has a much higher average read depth of 562. In summary, no strong 
evidence for off-target or ectopic recombination caused by SCRaMbLE was found from our 
sequencing data. 
 
4.2.3 Full sequence reconstruction 
“SCRaMbLEgrams” was used to depict the segment order and orientation for each strain (Figure 4.3). 
Each strain had a unique structure; the diverse recombinations and resulting genomes support the use 
of SCRaMbLE to generate combinatorial diversity through random recombinations between 
loxPsym sites. Simple deletions ranged in length from 1 to 16 segments, or 135 to 41,999 bp. The 
largest simple inversion was in JS611, involving 20 segments and extending over 38,925 bp. The 
strain JS613, with the greatest number of simple recombinations that could be unambiguously 
mapped, had 8 simple deletions and 2 simple inversions. Compared to uninduced SynIXR, 6 hour 
induction of SynIXR led to 10-fold fewer viable colonies; 12 hour induction to about 100-fold fewer 
colonies; and longer induction periods to 1000-fold fewer colonies16, providing indirect but strong 




Figure 4.3 Rearrangements observed in SynIXR SCRaMbLE strains 
Each SCRaMbLE strain is represented as a sequence of arrows. The colour of each arrow indicates the 
segment number in the parental chromosome, and the direction of the arrow represents the orientation 
(SCRaMbLEgram visualization). A red border denotes a segment containing an essential gene. The 
names of slow growth strains are indicated in red text. 
 
The observed SynIXR junctions were then used as inputs to Euclidean path algorithms to reconstruct 
the rearranged chromosomes (Figure 4.2). These algorithms require only linear time to check the 
existence of a sequence consistent with the observed loxPsym junctions, and then near-linear time to 
reconstruct feasible solutions. For 39 of the scrambled SynIXR strains, junctions in the 500 bp library 
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helped derive a unique reconstruction (Table 4.1). The remaining strains had more than one possible 
reconstruction because the insert size was insufficient to resolve rearrangements involving large 
duplications and higher amplifications. Strain JS735, for example, has 41 parental junctions, 33 novel 





Table 4.1 SCRaMbLE analysis summary of SynIXR and BY4741 strains 
 
Therefore, long-insert libraries were used to constrain and reduce the number of feasible solutions 
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and found to be powerful. Of the 25 strains with multiple solutions, 10 were chosen for long-insert 
sequencing. Each of these strains had at least 100 feasible solutions with the short-insert library, and 
two had over 100,000 solutions. Long-insert reads reduced the number of solutions to 4 or fewer for 
each sequenced strain, except for JS707, whose over 1,000,000 feasible solutions from short inserts 
were reduced to 48 feasible solutions. 
Recombination events were classified as deletions, inversions, tandem and inverted duplications, and 
more complex rearrangements with respect to the parental SynIXR sequence (Figure 4.4). Most 
frequently retained segments were mostly a single copy (Figure 4.5A), and, as expected, essential 
genes and the centromere are retained in all strains. Segments 19 and 24, which lack essential genes 
but contain genes required for fast growth, are also retained in all strains. The MRS1 gene in segment 
19 is essential for mitochondrial gene expression121. Segment 19 is also immediately upstream of 
essential gene SEC11 on segment 20, and each strain also retains the 19R-20L junction; segment 19 
might therefore contain regulatory elements required for proper SEC11 expression. Segment 24 
contains YVH1, and YVH1 knockouts confer slow growth121. Auxotrophy screening previously 
performed on the strains chosen for study generated deletion peaks close to segment 14 (containing 
MET28) and segment 32 (LYS1) as expected (Figure 4.5A). The segment containing MET28 is close 
to essential genes in segments 12 and 20, accordingly, deletions of MET28 do not extend beyond 
these limits. Deletions of LYS1 can be much larger, with the closest essential segments in the circular 
chromosome being 20 and 2.  
 
While the SCRaMbLE system was designed primarily to generate deletions and inversions, 
duplications were also found to be surprisingly frequent and widespread. At least one duplication 
occurred in 31 of the 64 SynIXR strains, and each of the 43 segments is amplified in at least one strain 
(Figure 4.5B). Prolific amplifications, sometimes spanning most of the surviving regions of SynIXR, 
suggest that duplications of genes on SynIXR do not incur a strong fitness defect, even for essential 
genes (p-value: 0.329, two-sided t-test for the number of strains with essential vs. non-essential 
segments amplified). Amplifications may arise from the double rolling circle mechanism, which can 
amplify micron plasmids122,123 and has recently been used in engineered systems as a model for gene 
amplifications in cancer124. Double rolling circle amplification may occur when loxPsym sites 
recombine across a replication fork within a DNA replication bubble, creating a topology in which 
replication forks travel in the same direction around the bubble until one is reversed by a second 
recombination. Unequal crossing over between two loxP sites during the late S or G2 phases is 




Figure 4.4 Recombination events of SynIXR SCRaMbLEd strains 
The fate of each segment in each strain in indicated as deleted (gray), inverted (blue), tandem duplication 





Figure 4.5 Copy number distribution of segments in SynIXR 
A. The distribution of copy number for each segment is shown across strains. B. Each segment was 
involved in at least one duplication event.  
 
While the mean number of events per strain was 6.2 ± 4.9 (Figure 4.6), the distribution of events per 
strain has a long tail, with 18 events observed in one strain (Figure 4.7A). The loxPsym site was 
designed to allow recombination in both directions, which, regardless of fitness effects and subtle 
differences in DNA bending required for deletion versus inversion, should result in equal numbers 
of these types of events. While 156 total deletions were observed, 63 of these were required by 
phenotypic selection. The remaining 93 deletion events were indistinguishable from the 89 inversion 
events (P = 0.83, Poisson test for rates). Similarly, 50 tandem duplications and 44 inverted 
duplications were observed, at roughly equal frequencies (P = 0.66, Poisson test for rates). 
Recombination event frequencies negatively correlate with the distance between loxPsym sites prior 
to an event (Figure 4.7B). Deletions are further limited in length by the requirement to retain essential 
genes. Inversion frequencies also decay with length, consistent with statistical probabilities of DNA 
looping125,126, and more slowly than the length decay of deletions.  
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Figure 4.6 SCRaMbLE events of SynIXR strains 
The number of SCRaMbLE events of each type is depicted for each strain, with the number of events 
per strain is 6.2 ± 4.9.  
 
 
Figure 4.7 Number and variation length of different types of events in SCRaMbLEd SynIXR 
A. The number of events per strain has a long tail, with strains observed having 17 and 18 distinct 
recombination events. B. Events are more likely at short distances but continue to be observed for long 
separations between recombination sites. There is a preponderance of deletions over inversions at the 
short lengths.  
 
To summarize, the analysis of 63 SynIXR SCRaMbLEd strains relative to the parental SynIXR strain 
using the established analysis pipeline shows that SCRaMbLE combines designed recombination 
sites with controlled expression of recombinase for efficient, robust generation of genomic diversity. 
Deep sequencing of yeast strains before and after SCRaMbLE demonstrates that the parental genome 
is stable, with no evidence for recombination outside the designed sites. Observed variations include 
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deletions, inversions and duplications. Deletion frequencies readily identify genes required for high 
fitness. The double rolling circle mechanism likely contributes to the amplification of large regions, 
which is predicted to produce useful “gain-of-function” phenotypes.  
 
4.3 Fitness defect rescue of SynII by SCRaMbLE 
Genome reconstruction analysis of circular SynIXR shows that SCRaMbLE system will be valuable 
in combinatorial exploration of genomic diversity for gene-gene and gene-environment interactions 
and phenotype-based selections. During the construction of Sc2.0 chromosomes, given that some 
defects might involve more than one bug, the complementation method used for construction of SynII 
may not be applicable (Details can be found in Chapter Two). In this case, SCRaMbLE may provide 
a powerful alternative approach for correcting any defect that arise.  
Here, the feasibility of this approach has been demonstrated by quickly evolving a SynII deriviative 
to identify and overcome a design problem. By turning on the SCRaMbLE system in synII cells and 
directly cultivating the SCRaMbLEd population in conditions that appear the defect, a few wild type-
like large colonies were identified (Figure 4.8A). From two large colonies isolated for sequencing, 
no rearrangement was observed within or near the YBR265W gene, in which the synonymously 
recoded PCRTag altered YBR265W protein level and led to the defect. However, all genomic 
rearrangements on SynII involve genes coding for regulatory proteins that have either genetic or 
physical interactions with high osmolarity glycerol (HOG) regulatory proteins (Figure 4.8B). It is 
also interesting to see that a phenotypic defect can be rescued through a number of different routes 




Figure 4.8 SynII defect at 37°C on YPG media can be rescued by SCRaMbLE 
A. Screening the SCRaMbLEd SynII colonies with recovered phenotype. Two large colonies were 
isolated for sequencing verification (red arrows). B. Genome rearrangements identified on SynII in growth 
recovery strains. Inversions and deletions are highlighted in green and red respectively. Genes involving 
the HOG response regulation are listed. RPS6B, MUM2 and ISW1 were deleted (Red) and KTR4 
generated a convergent ORF (CDS-CDS) in an inversion (Green). 
 
4.4 Conclusion and discussion 
This chapter started with the introduction of a genome analysis pipeline developed for detailed 
analysis of SCRaMbLEd Sc2.0 strains. And from the analysis of 64 SCRaMbLEd SynIXR strains, a 
few conclusions of the SCRaMbLE system can be addressed: 
First, analysis of 63 synIXR SCRaMbLE strains confirms that the synthetic system functions as 
designed. In the absence of Cre induction, the parental chromosome remained stable. For induced 
strains, no off-target recombination events were observed as all novel junctions were derived from 
designed loxPsym sites, with no ectopic recombinations or other rearrangements observed. Studies 
of SynIII strain also support this conclusion17. However, instead of integrating Cre-EBD in the 
genome, it is better to provide Cre-EBD on a plasmid as leaky expression from integrated Cre-EBD 
could lead to continued recombinations in the absence of estradiol induction.  
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Second, short-insert libraries were sufficient to characterize the recombination junctions and copy 
number variations for every strain and provided unambiguous genome structures for most 
SCRaMbLEd strains. For strains with multiple solutions yielded by short read sequencing, additional 
sequencing with long-insert libraries helped to narrow down the number of solutions. The result of 
SynIXR SCRaMbLEd strains demonstrates that a combination of short-insert and long-insert 
sequencing can be sufficient to determine genome structure even for highly rearranged and duplicated 
SCRaMbLEd genomes.  
Third, each strain had a unique genome, demonstrating the ability of SCRaMbLE to generate 
genomic diversity. The spectrum of loxPsym recombinations was consistent with retention of 
essential genes and selection for loss of phenotypic markers. Recombination hotspots and cold-spots 
in general may depend on selection pressure. Deletion patterns from SCRaMbLE provided ample 
information to identify all annotated essential and slow-growth genes. The ability of SCRaMbLE to 
generate gene amplifications may permit evolution of new functions.  
Several applications of SCRaMbLE with synthetic yeast strains were presented in this chapter. First, 
we found SynII strain has fitness defect under a specific growth condition (glycerol as carbon source 
and growth temperature at 37°C). The strength of SCRaMbLE was demonstrated by generating SynII 
strains with restored tolerance to this stress condition. In the previous chapter, YBR265W gene was 
found carrying a recoded PCRTag that is responsible for the defect. However, SCRaMbLE analysis 
revealed that ideletions and inversions obtained in the two SCRaMbLEd SynII strains involve genes 
(RPS6B, MUM2, ISW1 and KTR4) which are all involved or interact with the HOG response 
regulatory pathway.  
Applications of SCRaMbLE have also been attempted by other studies. For example, SCRaMbLE 
has been used to generate strains with increased tolerance to several stress conditions, such as ethanol, 
heat and acetic acid127.  In addition, SCRaMbLE has been applied for exogenous pathway 
optimization and chassis engineering128. It is encouraging to see that this system could be used in 
combination with directed evolution to further increase permutations and potentially lead to more 
desired new strains. The power of SCRaMbLE is not only to identify strains, but also to dissect the 
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potential underlying mechanisms through the combination of other genetics tools, phenotypic assays 
and sequencing efforts. Therefore, the system holds great potential for fundamental biology studies 
and industrial applications. With the merging of multiple synthetic chromosomes and the complete 
synthesis of the whole yeast genome in near future, more applications for the SCRaMbLE system 
will emerge.   
 
4.5 Materials and methods 
 
Sequencing Library preparation  
The sequencing libraries were made without PCR amplification to avoid creating junction artifacts 
through crossover PCR driven by hybridization of loxPsym sites. In addition, in order to accurately 
estimate copy number of target regions, amplification-free sequencing decreased the likelihood that 
an appreciable proportion of these sequences would be duplicates and preserved a more even 
distribution of read coverage across the targeted sequencing regions129. Cultures of reference and 
SCRaMbLE strains were grown in 30 mL YPD at 30°C until saturated. DNA was extracted by the 
glass beads method130, and the amplicon-free libraries were prepared following the Illumina protocol. 
Ten micrograms of DNA were sheared using a Covaris S2 to an average length of 500 bp, end-
repaired, and ligated to Illumina paired-end adapters. Ligated fragments were selected on agarose 
gels and purified to yield the corresponding libraries. A large amplicon library of average length 10 
kb was also prepared for 10 strains by published methods120. All constructed libraries were sequenced 
on the Illumina HiSeq 2000 platform.  
 
Mapping to the parental genome  
Illumina HiSeq 2000 paired-end short reads were trimmed to remove adapter sequence. Then strict 
filtering was used to remove <100 bp or duplicated reads. Reads with unknown bases or with bases 
having a Phred-score below seven were removed. Filtered reads were mapped to the SynIXR 
reference sequences JN020955 using the SOAP short-read aligner (http://soap.genomics.org. cn/) for 
standard data processing of reads mapping to the parental genome with no rearrangements96. For the 
nonsynthetic chromosomes, BY4741 served as the reference. Paired-end reads that could not be 
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mapped directly were analyzed using Bowtie84 using standard settings.  
 
Splitting reads for junction identification  
Reads containing loxPsym sites that did not map to the parental genome, with at least 15 bp of 
sequence flanking the loxPsym site, were then trisected into a loxPsym site and two single ends, 
which remain associated with the paired sequence from the other end of the fragment. The two single 
ends were then aligned to the reference using Bowtie 2131 by single-end mapping to determine a novel 
loxPsym junction, with at least three reads required for support.  
 
Ectopic and parental structural variant detection  
Reads without loxPsym sites that did not map to the parental genome were directly split into two 
ends. In order to precisely locate a possible breakpoint, the split site was scanned over all intermediate 
positions at least 15 bp from the ends of the read. Then the two ends were aligned to the reference 
using Bowtie 2 by single-end mapping with parameter –k 100 for breakpoint detection, which could 
provide direct evidence of an ectopic recombination. For each identified breakpoint, a 5-bp error 
range was allowed. For a pre-existing parental variation relative to the BY4741_v2 reference, a 15-
bp error range was allowed and at least two reads per sample were required for identifying pre-
existing breakpoints.  
To detect recombination events outside of the designed target loxPsym site, we also applied CREST 
(Clipping REveals STructure), an algorithm that detects genomic structural variations at single base 
resolution132. A sequence read that spans a breakpoint will have partial alignment to both sides of the 
junction. Therefore, BWA96 was used first to perform local alignment to all generated reads after 
quality control. The unaligned portion of reads were masked by a process termed “soft-clipping” 
because the unaligned subsequence is retained but not trimmed even though it does not map to the 
current genomic location. Then soft-clipped reads were extracted from the binary alignment/map 
(BAM) file. First, soft-clipped reads at a putative breakpoint were assembled into a contig; the contig 
was then mapped against the reference genome to identify candidate partner breakpoints; then all 
possible soft-clipped reads were identified and assembled into a contig, followed by an alignment of 
the contig derived from the partner back to the reference genome. Finally, a match to the initial 
breakpoint was performed to check whether the breakpoint prediction was correct. All breakpoints 
with read depth close to the average depth involved recombinations between pairs of designed 
loxPsym sites.  
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Copy number variation  
Copy numbers were estimated to detect deletions, duplications, and higher amplifications. The 
average sequencing depth of SynIXR was 29.02. Then every segment with read depth of less than 
five was marked as deleted. After proceeding with the copy number estimation algorithm below, the 
average read depth for deleted segments was 0.27 and the maximum was 4.98. Segments 1 and 38 
exhibit a read depth close to five when deleted because reads from homologous regions in the genome 
are erroneously mapped. To account for possible systematic bias in sequencing depth due to 
confounding factors from library preparation and mapping, an iterative algorithm was used to refine 
the copy number estimation and the potential bias.  
 
Structural variation and genome reconstruction  
Each rearranged genome, denoted T, was represented by an undirected graph G = (V,E). The vertices 
V represented the segments of T, integer values with magnitude one through the total number of 
segments L (in this case 43) and sign indicating direction relative to the reference. The edges E 
represented the junctional-reads for adjacent segments. For each tandem duplication of segment i 
with copy number Ni, Ni − 1 vertices were added to the graph and connected as a ring. Given this 
graph G, the rearranged genome sequence was reconstructed by finding a cycle that visits each edge 
in G once, termed a Eulerian cycle over G. Algorithms based on Eulerian cycles have become 
standard in DNA sequence assembly. First the existence of a Eulerian cycle was checked by verifying 
that each vertex has an even degree and all belong to one and only one connected component; these 
operations can be performed in linear time. While it is possible that a mixture of two distinct genomes 
may lead to no cycles being found, in each case we found at least one Eulerian cycle. Multiple 
Eulerian cycle solutions were found in some cases. These result from rearrangements that extend 
farther than the length of the paired-end library and introduce ambiguities similar to genome 
assembly with long repeats. The multiple solutions have equal length and identical composition of 
segments and segment junctions.  
 
Long-insert libraries  
Paired-end reads from long-insert libraries with fragment sizes of ∼10 kb were used to constrain the 
solutions for the 10 strains with complex rearrangements. Quality thresholds for sequencing reads 
from the 10-kb library were the same as for the 500- bp library. The reads of ∼90 bp were aligned to 
the reference (Ref Strain: BY4741, the original right arm sequence of Chromosome 9 was replaced 
with the synthetic sequence) using SOAPaligner 2.2196, available at http://soap.genomics.org.cn/ 
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soapaligner.html, with parameters -m 7500 -x 12500 -r 1 -v 4 –R.  
 
Classifying recombination events  
Duplication events were identified as repeating regions of the reconstruction genome. Repeating 
regions in the same direction were further classified as tandem duplications and repeat regions in the 
opposite orientation were classified as inverted duplications. Subregions with the opposite direction 
within repeat and non-repeat regions were identified as inversion events. Deletion events were 
identified as segments with copy number of zero. A junction between two repeat regions or between 
a repeat and a non-repeat region was classified as a duplication junction. A junction between an 
inversion and a non-inversion region was an inversion junction. A deletion junction was a junction 
between two segments that are adjacent to the left end and the right end of a deleted region in the 
parental genome. Non-parental junctions not associated with the endpoints of deletion, duplication, 
or inversion events were classified as complex junctions. Contiguous regions of complex junctions 
were defined as a single complex event.  
Cre SCRaMbLE of SynII 
BY4741 and SynII with pSCW11-CreEBD-His3133 plasmid were cultured in SC–His liquid media 
overnight at 30°C, with duplicates for each strain. Cells were inoculated into SC–His liquid medium 
with 1 µM EST and cultured for 24 hrs at 30°C. Then cells were washed, serial diluted and spotted 





Overview and perspectives 
In this thesis, I have presented three major areas that are the focus of my research and explained their 
contributions in the development of yeast synthetic genomics. The first part focused on the 
development of a highly efficient and cost-effective DNA construction strategy for megabase long 
chromosomes for the Sc2.0 project, which holds the potential to be applied for genome-scale 
construction in other organisms. The second part provided details on the use of an extensive trans-
omics approach to dissect the fitness of strains carrying synthetic chromosomes, which facilitate the 
identification of subtle phenotypic changes at different levels. In the third part, the SCRaMbLE 
system is discussed in detail. Although several other debugging methods are explained in the second 
part, SCRaMbLE offers a new way of studying how the model organism, yeast, can adapt to 
challenging conditions by systemically altering its genomic content.  
The Sc2.0 project is considered to be a current landmark of synthetic genomics. To date, over one-
third of the S. cerevisiae chromosomes have been individually constructed by now. Meanwhile, a 
method has also been developed to build up a polysynthetic strain20. Through the dedicated efforts 
of the Sc2.0 consortium, it is expected that this will be realised in the near future the completion of 
Sc2.0 strain carrying all synthetic chromosomes as well as the tRNA neochromosome.  
The Sc2.0 strain will be useful to answer biological questions, e.g. how the synthetic strain adapts to 
incorporate an extra neochromosome carrying all tRNA genes. If the final Sc2.0 strain maintains a 
wild type like phenotype, this would suggest that gene order might not be a major contributor to cell 
viability. Then one of the next design frontiers might be to focus on reorganizing the whole genome 
into several contiguous DNA cassettes, which represent known biological functions. The majority of 
the 250-300 introns in native budding yeast genome have been removed from the Sc2.0 synthetic 
chromosomes. Ribosomal introns are still retained as a previous study showed that deletion of introns 
encoded within certain ribosomal protein genes has led to fitness defects69. Intriguingly, exclusion of 
all ribosomal introns from SynII did not seem to affect fitness under several growth conditions 
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examined so far (Yue Shen, et al. unpublished). One possible explanation is that all ribosomal 
proteins on SynII have duplicate copies on other chromosomes, and this might have contributed to 
maintain the wild-type like phenotype. It will be interesting, in future studies, to further examine the 
possibility of constructing a completely intron-free Sc2.0 strain.  
The Sc2.0 project represents the first genome-scale synthesis effort in any eukaryotic organism. 
Although sequencing, analyzing, editing and synthesis techniques continue to advance at lightning 
speed, genome-scale synthesis is still limited to relatively small genomes. Discussions on building 
large, gigabase (Gb)-sized genomes, for both animals and plants, to further our understanding of 
genetic blueprints have been ongoing23. The consensus is that combining de novo genome synthesis 
and genome editing (here we call this combination ‘genome-write’) may constitute a superior 
approach for assembling large artificial genomes134. The homologous recombination efficiency in 
cells from advanced species may not be as high as that in yeasts, thus in vivo genome editing tools, 
such as CRISPR/Cas9, are necessary for homology-independent targeted integration of synthetic 
DNA fragments in both dividing and non-dividing cells in vitro and, more importantly, in vivo (for 
example, in neurons of postnatal mammals) 135.  
Genome-write technologies will definitely improve our understanding of many fundamental 
biological questions.  
One of the most ambitious genome-write projects is to generate a synthetic cell with a functional 
synthetic genome. The need to design an artificial genome comes from a fundamental question: what 
is gene essentiality? The essentiality of cellular pathways can be context dependent and evolvable in 
all kingdoms of life136. Essential pathways are mostly tasked with basic and fundamental cellular 
functions that support cell/organism viability. In order to adapt to the extrinsic environment, cellular 
metabolic pathways often undergo extensive evolution, resulting in the development of a series of 
complex secondary metabolic mechanisms. It has been a long-standing interest and effort to study 
the biological processes and metabolic pathways of natural cells and organisms and in this regard 
synthetic genomics can provide a different perspective. For example, recently Hutchison et al. 
reported the design and construction of a synthesized minimal M. mycoides genome containing only 
473 genes, which is half the size of the native genome. Surprisingly, among these 473 genes, they 
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found there are still over one hundred genes with unknown functions, but seemingly essential for cell 
viability62.  
Another future focus could be the rewriting of the genetic coding rules. Genome write does not have 
to follow the existing rules of genetic encoding and decoding, thereby holding potential to create new 
life forms that do not exist in nature. Although different organisms differ vastly in many aspects, their 
genomes are encoded by the same four nucleotides, and their proteins are assembled with the same 
20 types of amino acids. Synthetic organisms, on the other hand, may be designed to incorporate 
additional types of nucleotides into their genomes and non-canonical amino acids into their proteins. 
By altering the codon rules and using modified tRNAs, new proteins containing non-canonical amino 
acids can be obtained. Lajoie et al. replaced all TAG stop codons with the TAA stop codons and 
reassigned TAG codon to a non-standard amino acid in bacteria137. Similar efforts have also been 
applied in the Sc2.0 project70. Very recently, Zhang et al. incorporated unnatural base pairs into DNA 
and non-canonical amino acids into GFP with the use of specific tRNA138. These studies expanded 
the repertoire for DNA replication, transcription and translation, thereby paving the way for the 
creation of a variety of artificial organisms with special features. 
Last but not least, one of the major genome-write applications is therapeutics. Genome-wide 
association studies (GWAS) have revealed countless small or large variations that might be associated 
with medically important phenotypes 139. Many studies are trying to establish causal relationships 
between particular mutations and specific diseases, especially for single gene disorders. Subsequently, 
repair of such defects could be realized by introducing synthetic DNA with the mutation eliminated 
by genome editing tools.  
Despite the potential mentioned above, however, there remain many challenges that require 
continued investment and effort before full-fledged genome-write applications become possible:  
First, we need to continue improving our understanding of cellular biological processes and 
metabolic pathways, which is a prerequisite for developing any new synthetic biology design and 
applications. There are more than eight million different species living on Earth. Among them, many 
are complex multicellular organisms that have a multitude of cell types with different compositions 
and functions. These cells share common fundamental metabolism, but also differ in specific 
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metabolic pathway(s). What are the factors involved, and what are the relations between these factors? 
Many researches are needed to answer these questions.  
Second, new technologies are needed to further reduce the cost of genome synthesis and targeted 
integration/delivery. At present, implementing a large-scale synthetic genomic project is still costly 
and time consuming. The synthetic DNA fragment is first synthesized as oligonucleotides by a 
chemical method, then assembled into larger pieces through multiple DNA assembly techniques. Due 
to the limited efficiency of chemical-based DNA synthesis, the efficiency of synthesizing 
oligonucleotides more than 200 bases is quite challenging. Therefore, new methods which can 
improve the chemistry reaction efficiency or techniques that use enzymes to synthesize long DNA 
are necessary. For targeted integration of synthetic DNA, the current techniques are still inefficient 
in precision delivery, while the size the synthetic DNA to be delivered is also limited. Customizable 
nuclease-based genome editing relies on the cell’s intrinsic DNA double-strand break (DSB) repair 
mechanism. Due to the difficulty of precisely controlling the DNA repair process, homology directed 
repair (HDR) based error-free repair efficiency is inherently low. Thus, new genome editing tools 
which will allow large pieces of DNA (from 100 kb to megabase scale) to be delivered into host cells 
in designated site are needed.  
Third, public engagement is needed for addressing bioethics and biosafety concerns. Synthetic 
biology has made it easy to synthesise human-animal chimeric genomes. An organism containing 
both human and animal genetic material can be made by incorporating large amounts of human 
genomic fragments into an animal genome, or vice versa. Depending on the degree of genomic 
mixing, it may become increasingly difficult to define the species identity of the generated cells 
and/or organisms. In addition, it has been reported that synthetic viruses can have the same infectivity 
as the natural virus140. These synthetic pathogens may be used for criminal activities that endanger 
public safety. Therefore, we must take extreme precautions to prevent synthetic biology technologies 
from being used to engineer toxic, infectious and other harmful organisms or biological materials. 
In general, synthetic biology (synthetic genomics in particular) marks a new era in the field of biology. 
In contrast to physics and chemistry, there are no simple and straightforward principles to follow to 
develop applications in biology. Biological processes in all species are black boxes with extremely 
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complex structures and functions. Understanding of the underlying rules is prerequisite for 
developing applications for every discipline. In the past century, biological studies have undergone 
rapid development and revolutionized our understanding of organism heredity and development. 
These consequently laid an important foundation for the birth of synthetic biology. In the future, with 
a combination of genome writing technology, genetic circuit technology, new genetic encoding and 
decoding technology, etc. we might be able to create new species or resuscitate extinct species in 
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